BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akbar A, Yiangou Y, Facer P, Walters JR, Anand P, Ghosh S. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut 2008;57:923-9. [PMID: 18252749 DOI: 10.1136/gut.2007.138982] [Cited by in Crossref: 345] [Cited by in F6Publishing: 372] [Article Influence: 24.6] [Reference Citation Analysis]
Number Citing Articles
1 Mobasheri F, Shidfar F, Aminianfar A, Keshteli AH, Esmaillzadeh A, Adibi P. The association between dietary acid load and odds and severity of irritable bowel syndrome in adults. Sci Rep 2022;12:18943. [DOI: 10.1038/s41598-022-23098-9] [Reference Citation Analysis]
2 Anand U, Pacchetti B, Anand P, Sodergren MH. The Endocannabinoid Analgesic Entourage Effect: Investigations in Cultured DRG Neurons. JPR 2022;Volume 15:3493-3507. [DOI: 10.2147/jpr.s378876] [Reference Citation Analysis]
3 Brierley SM, Greenwood-Van Meerveld B, Sarnelli G, Sharkey KA, Storr M, Tack J. Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome. Nat Rev Gastroenterol Hepatol 2022. [PMID: 36168049 DOI: 10.1038/s41575-022-00682-y] [Reference Citation Analysis]
4 Chang W, Yang Y, She M, Tu C, Lee T, Wu M, Sun C, Hsin L, Yu LC. 5-HT7 receptor-dependent intestinal neurite outgrowth contributes to visceral hypersensitivity in irritable bowel syndrome. Lab Invest 2022;102:1023-1037. [DOI: 10.1038/s41374-022-00800-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Ito K, Kanemitsu Y, Kamiya T, Fukumitsu K, Takeda N, Tajiri T, Kurokawa R, Nishiyama H, Yap J, Fukuda S, Uemura T, Ohkubo H, Maeno K, Ito Y, Oguri T, Takemura M, Niimi A. Functional gastrointestinal disorders are associated with capsaicin cough sensitivity in severe asthma. Allergology International 2022. [DOI: 10.1016/j.alit.2022.08.009] [Reference Citation Analysis]
6 Pardo-camacho C, Ganda Mall J, Martínez C, Pigrau M, Expósito E, Albert-bayo M, Melón-ardanaz E, Nieto A, Rodiño-janeiro B, Fortea M, Guagnozzi D, Rodriguez-urrutia A, Torres ID, Santos-briones I, Azpiroz F, Lobo B, Alonso-cotoner C, Santos J, González-castro AM, Vicario M. Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations. Cells 2022;11:2046. [DOI: 10.3390/cells11132046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Cheng L, Luo Q, Chen S, Nakamura M. Expression of TRP Channels in Colonic Mucosa of IBS-D Patients and Its Correlation with the Severity of the Disease. Gastroenterology Research and Practice 2022;2022:1-7. [DOI: 10.1155/2022/7294775] [Reference Citation Analysis]
8 Xiang Y, Xu X, Zhang T, Wu X, Fan D, Hu Y, Ding J, Yang X, Lou J, Du Q, Xu J, Xie R. Beneficial effects of dietary capsaicin in gastrointestinal health and disease. Experimental Cell Research 2022. [DOI: 10.1016/j.yexcr.2022.113227] [Reference Citation Analysis]
9 Liu Y, Lyu Y, Wang H. TRP Channels as Molecular Targets to Relieve Endocrine-Related Diseases. Front Mol Biosci 2022;9:895814. [DOI: 10.3389/fmolb.2022.895814] [Reference Citation Analysis]
10 Chu X, Zhuang H, Liu Y, Li J, Wang Y, Jiang Y, Zhang H, Zhao P, Chen Y, Jiang X, Wu Y, Bu W. Blocking Cancer-Nerve Crosstalk for Treatment of Metastatic Bone Cancer Pain. Adv Mater 2022;34:e2108653. [PMID: 35244228 DOI: 10.1002/adma.202108653] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Tao E, Zhu Z, Hu C, Long G, Chen B, Guo R, Fang M, Jiang M. Potential Roles of Enterochromaffin Cells in Early Life Stress-Induced Irritable Bowel Syndrome. Front Cell Neurosci 2022;16:837166. [DOI: 10.3389/fncel.2022.837166] [Reference Citation Analysis]
12 Bao C, Wu L, Shi Y, Shi Z, Jin X, Shen J, Li J, Hu Z, Chen J, Zeng X, Zhang W, Ma Z, Weng Z, Li J, Liu H, Wu H. Long-term effect of moxibustion on irritable bowel syndrome with diarrhea: a randomized clinical trial. Therap Adv Gastroenterol 2022;15:175628482210751. [DOI: 10.1177/17562848221075131] [Reference Citation Analysis]
13 Niu L, Wang J, Shen F, Gao J, Jiang M, Bai G. Magnolol and honokiol target TRPC4 to regulate extracellular calcium influx and relax intestinal smooth muscle. J Ethnopharmacol 2022;290:115105. [PMID: 35157953 DOI: 10.1016/j.jep.2022.115105] [Reference Citation Analysis]
14 Singh R, Zogg H, Ghoshal UC, Ro S. Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders. Front Pharmacol 2022;13:808195. [DOI: 10.3389/fphar.2022.808195] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Kim M, Heo G, Kim SY. Neural signalling of gut mechanosensation in ingestive and digestive processes. Nat Rev Neurosci 2022. [PMID: 34983992 DOI: 10.1038/s41583-021-00544-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
16 Pérez de Arce E, Quera R, Beltrán CJ, Madrid AM, Nos P. Irritable bowel syndrome in inflammatory bowel disease. Synergy in alterations of the gut-brain axis? Gastroenterología y Hepatología (English Edition) 2022;45:66-76. [DOI: 10.1016/j.gastre.2021.02.007] [Reference Citation Analysis]
17 Louwies T, Meerveld BG. Abdominal Pain. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00037-2] [Reference Citation Analysis]
18 Dolan RD, Rohani TS, Muttineni D, Mashimo H. The Physiology and Pharmacology of Diabetic Gastropathy Management. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00045-1] [Reference Citation Analysis]
19 Ní Dhonnabháín R, Xiao Q, O'Malley D. Aberrant Gut-To-Brain Signaling in Irritable Bowel Syndrome - The Role of Bile Acids. Front Endocrinol (Lausanne) 2021;12:745190. [PMID: 34917022 DOI: 10.3389/fendo.2021.745190] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
20 Layer P, Andresen V, Allescher H, Bischoff SC, Claßen M, Elsenbruch S, Freitag M, Frieling T, Gebhard M, Goebel-Stengel M, Häuser W, Holtmann G, Keller J, Kreis ME, Kruis W, Langhorst J, Jansen PL, Madisch A, Mönnikes H, Müller-Lissner S, Niesler B, Pehl C, Pohl D, Raithel M, Röhrig-Herzog G, Schemann M, Schmiedel S, Schwille-Kiuntke J, Storr M, Preiß JC, Andus T, Buderus S, Ehlert U, Engel M, Enninger A, Fischbach W, Gillessen A, Gschossmann J, Gundling F, Haag S, Helwig U, Hollerbach S, Karaus M, Katschinski M, Krammer H, Kuhlbusch-Zicklam R, Matthes H, Menge D, Miehlke S, Posovszky MC, Schaefert R, Schmidt-Choudhury A, Schwandner O, Schweinlin A, Seidl H, Stengel A, Tesarz J, van der Voort I, Voderholzer W, von Boyen G, von Schönfeld J, Wedel T; Collaborators:., in Zusammenarbeit mit:., Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM)., Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)., Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)., Deutsche Gesellschaft für Ernährungsmedizin (DGEM)., Deutsche Gesellschaft für Geriatrie (DGG)., Deutsche Gesellschaft für Innere Medizin (DGIM)., Deutsche Gesellschaft für Naturheilkunde (DGNHK)., Deutsche Gesellschaft für Pathologie und Bundesverband deutscher Pathologen e. V. (DGP/BDP)., Deutsche Gesellschaft für Psychosomatische Medizin und Ärztliche Psychotherapie (DGPM)., Deutsche Gesellschaft für Verhaltensmedizin und Verhaltensmodifikation (DGVM)., Deutsche Schmerzgesellschaft e. V., Deutsches Kollegium für Psychosomatische Medizin (DKPM), Deutsche Gesellschaft für Tropenmedizin und Internationale Gesundheit (DTG)., Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE)., Deutschen Gesellschaft für Kinder- und Jugendmedizin (DGKJ)., Swiss Society of Neurogastroenterology and Motility (SwissNGM)., Informationsforum für Patient:innen mit Magen-Darm-Erkrankungen (MAGDA). Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016. Z Gastroenterol 2021;59:1323-415. [PMID: 34891206 DOI: 10.1055/a-1591-4794] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
21 Kumar S, Singh P, Kumar A. Targeted therapy of irritable bowel syndrome with anti-inflammatory cytokines. Clin J Gastroenterol 2021. [PMID: 34862947 DOI: 10.1007/s12328-021-01555-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Schindler V, Hente J, Murray FR, Hüllner M, Becker AS, Giezendanner S, Schnurre L, Bordier V, Pohl D. Adding a liquid test meal to a standardized lactulose hydrogen breath test significantly influences abdominal symptom generation and hydrogen values. Eur J Gastroenterol Hepatol 2021;33:1485-94. [PMID: 34609811 DOI: 10.1097/MEG.0000000000002042] [Reference Citation Analysis]
23 Sun C, Yang X, Xie S, Zhou Z, Yu G, Feng S, Zhao J, Wu J, Ji C. A Comparison Study of the Effect on IBS-D Rats among Ginger-Partitioned Moxibustion, Mild Moxibustion, and Laser Moxibustion. Evid Based Complement Alternat Med 2021;2021:4296216. [PMID: 34840586 DOI: 10.1155/2021/4296216] [Reference Citation Analysis]
24 Lucarini E, Seguella L, Vincenzi M, Parisio C, Micheli L, Toti A, Corpetti C, Del Re A, Squillace S, Maftei D, Lattanzi R, Ghelardini C, Di Cesare Mannelli L, Esposito G. Role of Enteric Glia as Bridging Element between Gut Inflammation and Visceral Pain Consolidation during Acute Colitis in Rats. Biomedicines 2021;9:1671. [PMID: 34829900 DOI: 10.3390/biomedicines9111671] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
25 Choudhary A, Fikree A, Aziz Q. Overlap between irritable bowel syndrome and hypermobile Ehlers-Danlos syndrome: An unexplored clinical phenotype? Am J Med Genet C Semin Med Genet 2021. [PMID: 34741491 DOI: 10.1002/ajmg.c.31938] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Chen C, Yu Z, Lin D, Wang X, Zhang X, Ji F, He L, Xu B. Manual Acupuncture at ST37 Modulates TRPV1 in Rats with Acute Visceral Hyperalgesia via Phosphatidylinositol 3-Kinase/Akt Pathway. Evid Based Complement Alternat Med 2021;2021:5561999. [PMID: 34646326 DOI: 10.1155/2021/5561999] [Reference Citation Analysis]
27 Grover M, Berumen A, Peters S, Wei T, Breen-Lyles M, Harmsen WS, Busciglio I, Burton D, Vazquez Roque M, DeVault KR, Camilleri M, Wallace M, Dasari S, Neumann H, Houghton LA. Editorial: understanding IBS pathophysiology through "converging channels" of research-authors' reply. Aliment Pharmacol Ther 2021;54:1215-6. [PMID: 34637534 DOI: 10.1111/apt.16613] [Reference Citation Analysis]
28 Lu Y, Huang J, Zhang Y, Huang Z, Yan W, Zhou T, Wang Z, Liao L, Cao H, Tan B. Therapeutic Effects of Berberine Hydrochloride on Stress-Induced Diarrhea-Predominant Irritable Bowel Syndrome Rats by Inhibiting Neurotransmission in Colonic Smooth Muscle. Front Pharmacol 2021;12:596686. [PMID: 34594213 DOI: 10.3389/fphar.2021.596686] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
29 Xiang Q, Guo W, Tang X, Cui S, Zhang F, Liu X, Zhao J, Zhang H, Mao B, Chen W. Capsaicin—the spicy ingredient of chili peppers: A review of the gastrointestinal effects and mechanisms. Trends in Food Science & Technology 2021;116:755-65. [DOI: 10.1016/j.tifs.2021.08.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
30 Takahashi K, Khwaja IG, Schreyer JR, Bulmer D, Peiris M, Terai S, Aziz Q. Post-inflammatory Abdominal Pain in Patients with Inflammatory Bowel Disease During Remission: A Comprehensive Review. Crohn's & Colitis 360 2021;3. [DOI: 10.1093/crocol/otab073] [Reference Citation Analysis]
31 Wei L, Singh R, Ro S, Ghoshal UC. Gut microbiota dysbiosis in functional gastrointestinal disorders: Underpinning the symptoms and pathophysiology. JGH Open 2021;5:976-87. [PMID: 34584964 DOI: 10.1002/jgh3.12528] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
32 Grover M, Berumen A, Peters S, Wei T, Breen-Lyles M, Harmsen WS, Busciglio I, Burton D, Vazquez Roque M, DeVault KR, Camilleri M, Wallace M, Dasari S, Neumann H, Houghton LA. Intestinal chemosensitivity in irritable bowel syndrome associates with small intestinal TRPV channel expression. Aliment Pharmacol Ther 2021;54:1179-92. [PMID: 34472640 DOI: 10.1111/apt.16591] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
33 Videlock EJ, Chang L. Latest Insights on the Pathogenesis of Irritable Bowel Syndrome. Gastroenterol Clin North Am 2021;50:505-22. [PMID: 34304785 DOI: 10.1016/j.gtc.2021.04.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
34 Niu L, Hou Y, Jiang M, Bai G. The rich pharmacological activities of Magnolia officinalis and secondary effects based on significant intestinal contributions. J Ethnopharmacol 2021;281:114524. [PMID: 34400262 DOI: 10.1016/j.jep.2021.114524] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
35 Friesen C, Colombo JM, Deacy A, Schurman JV. An Update on the Assessment and Management of Pediatric Abdominal Pain. Pediatric Health Med Ther 2021;12:373-93. [PMID: 34393542 DOI: 10.2147/PHMT.S287719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
36 Fan L, Wong M, Fan XS, Hong Y, Sun K, Jiang C, Xie X, Wang HL. Quantitative Analysis of Intramucosal Mast Cells in Irritable Bowel Syndrome: A Comparison With Inflammatory Bowel Disease in Remission. J Clin Gastroenterol 2021;55:244-9. [PMID: 32649443 DOI: 10.1097/MCG.0000000000001394] [Reference Citation Analysis]
37 Roberts C, Albusoda A, Farmer AD, Aziz Q. Rectal Hypersensitivity in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Crohn's & Colitis 360 2021;3. [DOI: 10.1093/crocol/otab041] [Reference Citation Analysis]
38 Zhang Y, Feng L, Wang X, Fox M, Luo L, Du L, Chen B, Chen X, He H, Zhu S, Hu Z, Chen S, Long Y, Zhu Y, Xu L, Deng Y, Misselwitz B, Lang BM, Yilmaz B, Kim JJ, Owyang C, Dai N. Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea-predominant irritable bowel syndrome: a parallel-group, randomized controlled trial with analysis of clinical and microbiological factors associated with patient outcomes.Am J Clin Nutr. 2021;. [PMID: 33740048 DOI: 10.1093/ajcn/nqab005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 25.0] [Reference Citation Analysis]
39 Tan X, Pei W, Xie C, Wang Z, Liu J, Cheng Y, Mao T, Shi L, Zhao X, Lu Q, Sun Z, Kou F, Jiang H, Li J. Tongxie Anchang Decoction Relieves Visceral Hypersensitivity in Diarrhea-Predominant Irritable Bowel Syndrome Rats by Regulating the NGF/TrkA Signaling Pathway. Evid Based Complement Alternat Med 2021;2021:6679348. [PMID: 34239591 DOI: 10.1155/2021/6679348] [Reference Citation Analysis]
40 You XY, Zhang HY, Han X, Wang F, Zhuang PW, Zhang YJ. Intestinal Mucosal Barrier Is Regulated by Intestinal Tract Neuro-Immune Interplay. Front Pharmacol 2021;12:659716. [PMID: 34135754 DOI: 10.3389/fphar.2021.659716] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
41 Pérez de Arce E, Quera R, Beltrán CJ, Madrid AM, Nos P. Irritable Bowel Syndrome in Inflammatory Bowel Disease. Synergy in alterations of the gut-brain axis? Gastroenterol Hepatol 2021:S0210-5705(21)00143-6. [PMID: 34023477 DOI: 10.1016/j.gastrohep.2021.02.022] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 So SY, Savidge TC. Sex-Bias in Irritable Bowel Syndrome: Linking Steroids to the Gut-Brain Axis. Front Endocrinol (Lausanne) 2021;12:684096. [PMID: 34093447 DOI: 10.3389/fendo.2021.684096] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
43 Chai Y, He W, Yang W, Hetrick AP, Gonzalez JG, Sargsyan L, Wu H, Jung TTK, Li H. Intratympanic Lipopolysaccharide Elevates Systemic Fluorescent Gentamicin Uptake in the Cochlea. Laryngoscope 2021;131:E2573-82. [PMID: 33956344 DOI: 10.1002/lary.29610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Meng Q, Qin G, Yao SK, Fan GH, Dong F, Tan C. Differences in dietary habits of people with vs without irritable bowel syndrome and their association with symptom and psychological status: A pilot study. World J Clin Cases 2021; 9(11): 2487-2502 [PMID: 33889614 DOI: 10.12998/wjcc.v9.i11.2487] [Reference Citation Analysis]
45 Holland AM, Bon-Frauches AC, Keszthelyi D, Melotte V, Boesmans W. The enteric nervous system in gastrointestinal disease etiology. Cell Mol Life Sci 2021;78:4713-33. [PMID: 33770200 DOI: 10.1007/s00018-021-03812-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 16.0] [Reference Citation Analysis]
46 Price E, Gianfrancesco O, Harrison PT, Frank B, Bubb VJ, Quinn JP. CRISPR Deletion of a SVA Retrotransposon Demonstrates Function as a cis-Regulatory Element at the TRPV1/TRPV3 Intergenic Region. Int J Mol Sci 2021;22:1911. [PMID: 33671852 DOI: 10.3390/ijms22041911] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
47 Niesler B, Kuerten S, Demir IE, Schäfer KH. Disorders of the enteric nervous system - a holistic view. Nat Rev Gastroenterol Hepatol 2021;18:393-410. [PMID: 33514916 DOI: 10.1038/s41575-020-00385-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 35.0] [Reference Citation Analysis]
48 Ventura-Martinez R, Mares-Sánchez JJ, Avilés-Herrera J, Ángeles-López GE, Déciga-Campos M, González-Trujano ME, López-Muñoz FJ. Antinociceptive Synergy Between Metamizole and Hesperidin in a Model of Visceral Pain in Mice. Arch Med Res 2021;52:389-96. [PMID: 33483148 DOI: 10.1016/j.arcmed.2020.12.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
49 Mohanta S, Goswami C. TRP channels in the gut: Effect of probiotics and phyto-nutraceuticals on gut-brain-immune axis. Probiotic Beverages 2021. [DOI: 10.1016/b978-0-12-818588-9.00004-8] [Reference Citation Analysis]
50 Costa P. Neurophysiology of Visceral Pain. Urodynamics, Neurourology and Pelvic Floor Dysfunctions 2021. [DOI: 10.1007/978-3-030-56387-5_2] [Reference Citation Analysis]
51 Szałwińska P, Włodarczyk J, Spinelli A, Fichna J, Włodarczyk M. IBS-Symptoms in IBD Patients-Manifestation of Concomitant or Different Entities. J Clin Med 2020;10:E31. [PMID: 33374388 DOI: 10.3390/jcm10010031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
52 Duo L, Wu T, Ke Z, Hu L, Wang C, Teng G, Zhang W, Wang W, Ge Q, Yang Y, Dai Y. Gain of Function of Ion Channel TRPV1 Exacerbates Experimental Colitis by Promoting Dendritic Cell Activation. Mol Ther Nucleic Acids 2020;22:924-36. [PMID: 33251043 DOI: 10.1016/j.omtn.2020.10.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
53 Salvo-Romero E, Martínez C, Lobo B, Rodiño-Janeiro BK, Pigrau M, Sánchez-Chardi AD, González-Castro AM, Fortea M, Pardo-Camacho C, Nieto A, Expósito E, Guagnozzi D, Rodríguez-Urrutia A, de Torres I, Farré R, Azpiroz F, Alonso-Cotoner C, Santos J, Vicario M. Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome. Sci Rep 2020;10:20706. [PMID: 33244004 DOI: 10.1038/s41598-020-77176-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
54 Abdullah N, Defaye M, Altier C. Neural control of gut homeostasis. Am J Physiol Gastrointest Liver Physiol 2020;319:G718-32. [PMID: 33026824 DOI: 10.1152/ajpgi.00293.2020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
55 Constante M, De Palma G, Lu J, Jury J, Rondeau L, Caminero A, Collins SM, Verdu EF, Bercik P. Saccharomyces boulardii CNCM I-745 modulates the microbiota-gut-brain axis in a humanized mouse model of Irritable Bowel Syndrome. Neurogastroenterol Motil 2021;33:e13985. [PMID: 32955166 DOI: 10.1111/nmo.13985] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
56 Wright-McNaughton M, Ten Bokkel Huinink S, Frampton CMA, McCombie AM, Talley NJ, Skidmore PML, Gearry RB. Measuring Diet Intake and Gastrointestinal Symptoms in Irritable Bowel Syndrome: Validation of the Food and Symptom Times Diary. Clin Transl Gastroenterol 2019;10:e00103. [PMID: 31800544 DOI: 10.14309/ctg.0000000000000103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
57 Czajkowska M, Całka J. Neurochemistry of Enteric Neurons Following Prolonged Indomethacin Administration in the Porcine Duodenum. Front Pharmacol 2020;11:564457. [PMID: 33013401 DOI: 10.3389/fphar.2020.564457] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
58 Goldsteen PA, Dolga AM, Gosens R. Advanced Modeling of Peripheral Neuro-Effector Communication and -Plasticity. Physiology (Bethesda) 2020;35:348-57. [PMID: 32783607 DOI: 10.1152/physiol.00010.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
59 Pryor J, Burns GL, Duncanson K, Horvat JC, Walker MM, Talley NJ, Keely S. Functional Dyspepsia and Food: Immune Overlap with Food Sensitivity Disorders. Curr Gastroenterol Rep 2020;22:51. [PMID: 32797313 DOI: 10.1007/s11894-020-00789-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
60 Hetterich L, Stengel A. Ernährungsmedizinische Aspekte beim Reizdarmsyndrom – ein Update. Aktuelle Ernährungsmedizin 2020;45:276-285. [DOI: 10.1055/a-1086-5113] [Reference Citation Analysis]
61 Yang CQ, Guo XS, Ji-Li, Wei ZB, Zhao L, Zhao GT, Sheng ST. Rifaximin Improves Visceral Hyperalgesia via TRPV1 by Modulating Intestinal Flora in the Water Avoidance Stressed Rat. Gastroenterol Res Pract 2020;2020:4078681. [PMID: 32765600 DOI: 10.1155/2020/4078681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
62 Kwong KCL, Yeoh SC, Balasubramaniam R. Is oral dysaesthesia a somatic symptom disorder? J Oral Pathol Med 2020;49:499-504. [PMID: 32531871 DOI: 10.1111/jop.13064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Luo QQ, Wang B, Chen X, Qiu HY, Li WT, Yan XJ, Chen SL. Acute stress induces visceral hypersensitivity via glucocorticoid receptor-mediated membrane insertion of TRPM8: Involvement of a non-receptor tyrosine kinase Pyk2. Neurogastroenterol Motil 2020;32:1514-28. [PMID: 32391653 DOI: 10.1111/nmo.13877] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Matsui K, Terada Y, Tsubota M, Sekiguchi F, Kawabata A. Tacrolimus, a calcineurin inhibitor, promotes capsaicin-induced colonic pain in mice. Journal of Pharmacological Sciences 2020;143:60-63. [DOI: 10.1016/j.jphs.2020.01.006] [Reference Citation Analysis]
65 Osadchuk MA, Svistunov AA, Kireeva NV, Osadchuk MM. [Functional diseases of the gastrointestinal tract in the context with overlapping functional disorders: current status of the problem]. Ter Arkh 2020;92:111-8. [PMID: 32598728 DOI: 10.26442/00403660.2020.02.000458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Brugnatelli V, Turco F, Freo U, Zanette G. Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment. Front Neurosci 2020;14:371. [PMID: 32372912 DOI: 10.3389/fnins.2020.00371] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
67 Rosenfeld D, Senko AW, Moon J, Yick I, Varnavides G, Gregureć D, Koehler F, Chiang PH, Christiansen MG, Maeng LY, Widge AS, Anikeeva P. Transgene-free remote magnetothermal regulation of adrenal hormones. Sci Adv 2020;6:eaaz3734. [PMID: 32300655 DOI: 10.1126/sciadv.aaz3734] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 14.0] [Reference Citation Analysis]
68 Casado-Bedmar M, Keita ÅV. Potential neuro-immune therapeutic targets in irritable bowel syndrome. Therap Adv Gastroenterol 2020;13:1756284820910630. [PMID: 32313554 DOI: 10.1177/1756284820910630] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
69 Karatay E, Utku ÖG. Serum resolvin D1 levels as a marker of inflammation in constipation dominant irritable bowel syndrome. Turk J Gastroenterol 2020;31:113-9. [PMID: 32141819 DOI: 10.5152/tjg.2020.19751] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
70 Chen Y, Mu J, Zhu M, Mukherjee A, Zhang H. Transient Receptor Potential Channels and Inflammatory Bowel Disease. Front Immunol 2020;11:180. [PMID: 32153564 DOI: 10.3389/fimmu.2020.00180] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
71 Szymaszkiewicz A, Włodarczyk J, Wasilewski A, Di Marzo V, Storr M, Fichna J, Zielińska M. Desensitization of transient receptor potential vanilloid type-1 (TRPV1) channel as promising therapy of irritable bowel syndrome: characterization of the action of palvanil in the mouse gastrointestinal tract. Naunyn Schmiedebergs Arch Pharmacol 2020;393:1357-64. [PMID: 32002574 DOI: 10.1007/s00210-020-01829-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
72 Lee JY, Kim N, Park JH, Nam RH, Lee SM, Song CH, Kim G, Na HY, Choi YJ, Kim JJ, Lee DH. Expression of Neurotrophic Factors, Tight Junction Proteins, and Cytokines According to the Irritable Bowel Syndrome Subtype and Sex. J Neurogastroenterol Motil 2020;26:106-16. [PMID: 31623029 DOI: 10.5056/jnm19099] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
73 Pawlik L, Tarasiuk A. Irritable bowel syndrome and the brain-gut connection. A Comprehensive Overview of Irritable Bowel Syndrome 2020. [DOI: 10.1016/b978-0-12-821324-7.00003-4] [Reference Citation Analysis]
74 Henderson WA, Rahim-williams B. Genomics of Visceral Pain. Genomics of Pain and Co-Morbid Symptoms 2020. [DOI: 10.1007/978-3-030-21657-3_9] [Reference Citation Analysis]
75 Schemann M, Frieling T, Enck P. To learn, to remember, to forget-How smart is the gut? Acta Physiol (Oxf) 2020;228:e13296. [PMID: 31063665 DOI: 10.1111/apha.13296] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
76 Szczepaniak A, Zielińska M. The control of the intestinal epithelium integrity in irritable bowel syndrome patients. A Comprehensive Overview of Irritable Bowel Syndrome 2020. [DOI: 10.1016/b978-0-12-821324-7.00004-6] [Reference Citation Analysis]
77 Włodarczyk J, Szałwińska P. Pathogenesis of irritable bowel syndrome. A Comprehensive Overview of Irritable Bowel Syndrome 2020. [DOI: 10.1016/b978-0-12-821324-7.00002-2] [Reference Citation Analysis]
78 Sienkiewicz M. Diet in irritable bowel syndrome. A Comprehensive Overview of Irritable Bowel Syndrome 2020. [DOI: 10.1016/b978-0-12-821324-7.00013-7] [Reference Citation Analysis]
79 Świerczyński M, Szymaszkiewicz A. Non-pharmacological approach in irritable bowel syndrome therapy. A Comprehensive Overview of Irritable Bowel Syndrome 2020. [DOI: 10.1016/b978-0-12-821324-7.00014-9] [Reference Citation Analysis]
80 Kamal A, Pimentel M. Influence of Dietary Restriction on Irritable Bowel Syndrome. Am J Gastroenterol 2019;114:212-20. [PMID: 30315281 DOI: 10.1038/s41395-018-0241-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
81 Mischel RA, Muchhala KH, Dewey WL, Akbarali HI. The "Culture" of Pain Control: A Review of Opioid-Induced Dysbiosis (OID) in Antinociceptive Tolerance. J Pain 2020;21:751-62. [PMID: 31841668 DOI: 10.1016/j.jpain.2019.11.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
82 Pandey S, Kashif S, Youssef M, Sarwal S, Zraik H, Singh R, Rutkofsky IH. Endocannabinoid system in irritable bowel syndrome and cannabis as a therapy. Complement Ther Med 2020;48:102242. [PMID: 31987224 DOI: 10.1016/j.ctim.2019.102242] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
83 Alaimo A, Rubert J. The Pivotal Role of TRP Channels in Homeostasis and Diseases throughout the Gastrointestinal Tract. Int J Mol Sci 2019;20:E5277. [PMID: 31652951 DOI: 10.3390/ijms20215277] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
84 Defaye M, Gervason S, Altier C, Berthon JY, Ardid D, Filaire E, Carvalho FA. Microbiota: a novel regulator of pain. J Neural Transm (Vienna) 2020;127:445-65. [PMID: 31552496 DOI: 10.1007/s00702-019-02083-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
85 Sundin J, Nordlander S, Eutamene H, Alquier‐bacquie V, Cartier C, Theodorou V, Le Nevé B, Törnblom H, Simrén M, Öhman L. Colonic mast cell numbers, symptom profile, and mucosal expression of elements of the epithelial barrier in irritable bowel syndrome. Neurogastroenterology & Motility 2019;31. [DOI: 10.1111/nmo.13701] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
86 Wang K, Fang J, Qin X, Du G, Gao L. Uncovering the anti-metastasis effects and mechanisms of capsaicin against hepatocellular carcinoma cells by metabolomics. Journal of Functional Foods 2019;60:103431. [DOI: 10.1016/j.jff.2019.103431] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
87 Rej A, Aziz I, Tornblom H, Sanders DS, Simrén M. The role of diet in irritable bowel syndrome: implications for dietary advice. J Intern Med 2019;286:490-502. [DOI: 10.1111/joim.12966] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
88 Uno Y. Hypothesis: Mechanism of irritable bowel syndrome in inflammatory bowel disease. Med Hypotheses 2019;132:109324. [PMID: 31421429 DOI: 10.1016/j.mehy.2019.109324] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
89 López-Pérez AE, Nurgali K, Abalo R. Painful neurotrophins and their role in visceral pain. Behav Pharmacol 2018;29:120-39. [PMID: 29543647 DOI: 10.1097/FBP.0000000000000386] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
90 Mcconachie SM, Caputo RA, Wilhelm SM, Kale-pradhan PB. Efficacy of Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome: A Systematic Review. Ann Pharmacother 2019;53:1145-52. [DOI: 10.1177/1060028019852601] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
91 Wu Y, Wang Y, Wang J, Fan Q, Zhu J, Yang L, Rong W. TLR4 mediates upregulation and sensitization of TRPV1 in primary afferent neurons in 2,4,6-trinitrobenzene sulfate-induced colitis. Mol Pain 2019;15:1744806919830018. [PMID: 30672380 DOI: 10.1177/1744806919830018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
92 Hou N, He X, Yang Y, Fu J, Zhang W, Guo Z, Hu Y, Liang L, Xie W, Xiong H, Wang K, Pang M. TRPV1 Induced Apoptosis of Colorectal Cancer Cells by Activating Calcineurin-NFAT2-p53 Signaling Pathway. Biomed Res Int 2019;2019:6712536. [PMID: 31183372 DOI: 10.1155/2019/6712536] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
93 Zhu ZC, Wang HB, Yan XQ, Yang J, Duan XF, Bian HQ, Kuang HF. Serum substance P and vasoactive intestinal peptide levels in infants with acute intussusception. J Int Med Res 2019;47:2446-51. [PMID: 31006358 DOI: 10.1177/0300060519844401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
94 Johansson E, Lange S, Lönnroth I. Aromatic substances in wheat malt inducing antisecretory factor and resistance to diarrhoea. Journal of Functional Foods 2019;54:348-352. [DOI: 10.1016/j.jff.2019.01.034] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
95 Balemans D, Aguilera-lizarraga J, Florens MV, Jain P, Denadai-souza A, Viola MF, Alpizar YA, Van Der Merwe S, Vanden Berghe P, Talavera K, Vanner S, Wouters MM, Boeckxstaens GE. Histamine-mediated potentiation of transient receptor potential (TRP) ankyrin 1 and TRP vanilloid 4 signaling in submucosal neurons in patients with irritable bowel syndrome. American Journal of Physiology-Gastrointestinal and Liver Physiology 2019;316:G338-49. [DOI: 10.1152/ajpgi.00116.2018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
96 Gore R, Riedl MS, Kitto KF, Fairbanks CA, Vulchanova L. AAV-Mediated Gene Delivery to the Enteric Nervous System by Intracolonic Injection. Methods Mol Biol 2019;1950:407-15. [PMID: 30783988 DOI: 10.1007/978-1-4939-9139-6_24] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
97 Gajula P, Quigley EM. Overlapping irritable bowel syndrome and inflammatory bowel disease. Minerva Gastroenterol Dietol 2019;65:107-15. [PMID: 30746927 DOI: 10.23736/S1121-421X.19.02559-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
98 Salameh E, Meleine M, Gourcerol G, do Rego JC, do Rego JL, Legrand R, Breton J, Aziz M, Guérin C, Coëffier M, Savoye G, Marion-Letellier R. Chronic colitis-induced visceral pain is associated with increased anxiety during quiescent phase. Am J Physiol Gastrointest Liver Physiol 2019;316:G692-700. [PMID: 30735453 DOI: 10.1152/ajpgi.00248.2018] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
99 Mukhtar K, Nawaz H, Abid S. Functional gastrointestinal disorders and gut-brain axis: What does the future hold? World J Gastroenterol 2019; 25(5): 552-566 [PMID: 30774271 DOI: 10.3748/wjg.v25.i5.552] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 63] [Article Influence: 20.3] [Reference Citation Analysis]
100 Privitera R, Anand P. Visceral Pain and Hypersensitivity Disorders. Small Fiber Neuropathy and Related Syndromes: Pain and Neurodegeneration 2019. [DOI: 10.1007/978-981-13-3546-4_12] [Reference Citation Analysis]
101 Chidambaran V, Sadhasivam S. Pharmacogenomics. A Practice of Anesthesia for Infants and Children 2019. [DOI: 10.1016/b978-0-323-42974-0.00006-9] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
102 Kamal A, Padival R, Lashner B. Inflammatory Bowel Disease and Irritable Bowel Syndrome: What to Do When There Is an Overlap. Inflamm Bowel Dis 2018;24:2479-82. [PMID: 30169572 DOI: 10.1093/ibd/izy277] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
103 Colombo BB, Fattori V, Guazelli CFS, Zaninelli TH, Carvalho TT, Ferraz CR, Bussmann AJC, Ruiz-Miyazawa KW, Baracat MM, Casagrande R, Verri WA Jr. Vinpocetine Ameliorates Acetic Acid-Induced Colitis by Inhibiting NF-κB Activation in Mice. Inflammation 2018;41:1276-89. [PMID: 29633103 DOI: 10.1007/s10753-018-0776-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
104 Morales-Soto W, Gulbransen BD. Enteric Glia: A New Player in Abdominal Pain. Cell Mol Gastroenterol Hepatol 2019;7:433-45. [PMID: 30739868 DOI: 10.1016/j.jcmgh.2018.11.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
105 Weerts ZZRM, Keszthelyi D, Vork L, Aendekerk NCP, Frijlink HW, Brouwers JRBJ, Neef C, Jonkers DMAE, Masclee AAM. A Novel Ileocolonic Release Peppermint Oil Capsule for Treatment of Irritable Bowel Syndrome: A Phase I Study in Healthy Volunteers. Adv Ther 2018;35:1965-78. [PMID: 30284674 DOI: 10.1007/s12325-018-0802-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
106 De Gregorio D, Manchia M, Carpiniello B, Valtorta F, Nobile M, Gobbi G, Comai S. Role of palmitoylethanolamide (PEA) in depression: Translational evidence: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders. J Affect Disord 2019;255:S0165-0327(18)31599-4. [PMID: 30391203 DOI: 10.1016/j.jad.2018.10.117] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
107 Liang Q, Lv X, Cai Q, Cai Y, Zhao B, Li G. Novobiocin, a Newly Found TRPV1 Inhibitor, Attenuates the Expression of TRPV1 in Rat Intestine and Intestinal Epithelial Cell Line IEC-6. Front Pharmacol 2018;9:1171. [PMID: 30374305 DOI: 10.3389/fphar.2018.01171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
108 Naitou K, Nakamori H, Horii K, Kato K, Horii Y, Shimaoka H, Shiina T, Shimizu Y. Descending monoaminergic pathways projecting to the spinal defecation center enhance colorectal motility in rats. American Journal of Physiology-Gastrointestinal and Liver Physiology 2018;315:G631-7. [DOI: 10.1152/ajpgi.00178.2018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
109 Lin MJ, Yu BP. Upregulation of the high-affinity choline transporter in colon relieves stress-induced hyperalgesia. J Pain Res 2018;11:1971-82. [PMID: 30288092 DOI: 10.2147/JPR.S164186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
110 Tsigaridas A, Anagnostopoulos AK, Papadopoulou A, Ioakeim S, Vaiopoulou A, Papanikolaou IS, Viazis N, Karamanolis G, Mantzaris GJ, Tsangaris GT, Gazouli M. Identification of serum proteome signature of irritable bowel syndrome: Potential utility of the tool for early diagnosis and patient's stratification. Journal of Proteomics 2018;188:167-72. [DOI: 10.1016/j.jprot.2017.07.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
111 Van Gerven L, Steelant B, Hellings PW. Nasal hyperreactivity in rhinitis: A diagnostic and therapeutic challenge. Allergy 2018;73:1784-91. [PMID: 29624710 DOI: 10.1111/all.13453] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
112 Chittepu VCSR, Kalhotra P, Revilla GIO, Velázquez TG. Emerging Technologies to Improve Capsaicin Delivery and its Therapeutic Efficacy. Capsaicin and its Human Therapeutic Development 2018. [DOI: 10.5772/intechopen.77080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
113 Aktar R, Peiris M, Fikree A, Cibert-Goton V, Walmsley M, Tough IR, Watanabe P, Araujo EJA, Mohammed SD, Delalande JM, Bulmer DC, Scott SM, Cox HM, Voermans NC, Aziz Q, Blackshaw LA. The extracellular matrix glycoprotein tenascin-X regulates peripheral sensory and motor neurones. J Physiol. 2018;596:4237-4251. [PMID: 29917237 DOI: 10.1113/jp276300] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
114 Del Fiacco M, Serra MP, Boi M, Poddighe L, Demontis R, Carai A, Quartu M. TRPV1-Like Immunoreactivity in the Human Locus K, a Distinct Subregion of the Cuneate Nucleus. Cells 2018;7:E72. [PMID: 29986526 DOI: 10.3390/cells7070072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
115 Rizopoulos T, Papadaki-Petrou H, Assimakopoulou M. Expression Profiling of the Transient Receptor Potential Vanilloid (TRPV) Channels 1, 2, 3 and 4 in Mucosal Epithelium of Human Ulcerative Colitis. Cells 2018;7:E61. [PMID: 29914124 DOI: 10.3390/cells7060061] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
116 Hewawasam SP, Iacovou M, Muir JG, Gibson PR. Dietary practices and FODMAPs in South Asia: Applicability of the low FODMAP diet to patients with irritable bowel syndrome. J Gastroenterol Hepatol 2018;33:365-74. [PMID: 28700090 DOI: 10.1111/jgh.13885] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
117 Salvatierra J, Castro J, Erickson A, Li Q, Braz J, Gilchrist J, Grundy L, Rychkov GY, Deiteren A, Rais R, King GF, Slusher BS, Basbaum A, Pasricha PJ, Brierley SM, Bosmans F. NaV1.1 inhibition can reduce visceral hypersensitivity. JCI Insight 2018;3:121000. [PMID: 29875317 DOI: 10.1172/jci.insight.121000] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
118 Pei L, Chen H, Guo J, Chen L, Wu X, Xu W, Weng S, Yang E, Hammer T, Sun J. Effect of acupuncture and its influence on visceral hypersensitivity in IBS-D patients: Study protocol for a randomized controlled trial. Medicine (Baltimore) 2018;97:e10877. [PMID: 29794793 DOI: 10.1097/MD.0000000000010877] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
119 Anand U, Yiangou Y, Akbar A, Quick T, MacQuillan A, Fox M, Sinisi M, Korchev YE, Jones B, Bloom SR, Anand P. Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons. PLoS One 2018;13:e0198024. [PMID: 29813107 DOI: 10.1371/journal.pone.0198024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
120 Sadeghi M, Erickson A, Castro J, Deiteren A, Harrington AM, Grundy L, Adams DJ, Brierley SM. Contribution of membrane receptor signalling to chronic visceral pain. The International Journal of Biochemistry & Cell Biology 2018;98:10-23. [DOI: 10.1016/j.biocel.2018.02.017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
121 Adachi T. Visualization of Food Signals in Gut and Predisposition of Diseases by Intravital Imaging: Visualization of Ca<sup>2+</sup> Signals in the Living Body. KAGAKU TO SEIBUTSU 2018;56:345-352. [DOI: 10.1271/kagakutoseibutsu.56.345] [Reference Citation Analysis]
122 Mischel RA, Dewey WL, Akbarali HI. Tolerance to Morphine-Induced Inhibition of TTX-R Sodium Channels in Dorsal Root Ganglia Neurons Is Modulated by Gut-Derived Mediators. iScience 2018;2:193-209. [PMID: 29888757 DOI: 10.1016/j.isci.2018.03.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
123 Viganò D, Zara F, Usai P. Irritable bowel syndrome and endometriosis: New insights for old diseases. Digestive and Liver Disease 2018;50:213-9. [DOI: 10.1016/j.dld.2017.12.017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
124 Eller-Smith OC, Nicol AL, Christianson JA. Potential Mechanisms Underlying Centralized Pain and Emerging Therapeutic Interventions. Front Cell Neurosci 2018;12:35. [PMID: 29487504 DOI: 10.3389/fncel.2018.00035] [Cited by in Crossref: 93] [Cited by in F6Publishing: 103] [Article Influence: 23.3] [Reference Citation Analysis]
125 Fuentes IM, Pierce AN, Di Silvestro ER, Maloney MO, Christianson JA. Differential Influence of Early Life and Adult Stress on Urogenital Sensitivity and Function in Male Mice. Front Syst Neurosci 2017;11:97. [PMID: 29379420 DOI: 10.3389/fnsys.2017.00097] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
126 Jiang M, Taghizadeh F, Steyger PS. Potential Mechanisms Underlying Inflammation-Enhanced Aminoglycoside-Induced Cochleotoxicity. Front Cell Neurosci 2017;11:362. [PMID: 29209174 DOI: 10.3389/fncel.2017.00362] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
127 Lilli NL, Quénéhervé L, Haddara S, Brochard C, Aubert P, Rolli-Derkinderen M, Durand T, Naveilhan P, Hardouin JB, De Giorgio R, Barbara G, Bruley des Varannes S, Coron E, Neunlist M. Glioplasticity in irritable bowel syndrome. Neurogastroenterol Motil 2018;30:e13232. [PMID: 29027719 DOI: 10.1111/nmo.13232] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
128 Boyer J, Saint-paul M, Dadone B, Patouraux S, Vivinus M, Ouvrier D, Michiels J, Piche T, Tulic MK. Inflammatory cell distribution in colon mucosa as a new tool for diagnosis of irritable bowel syndrome: A promising pilot study. Neurogastroenterol Motil 2018;30:e13223. [DOI: 10.1111/nmo.13223] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
129 Lee YY, Annamalai C, Rao SSC. Post-Infectious Irritable Bowel Syndrome. Curr Gastroenterol Rep 2017;19. [DOI: 10.1007/s11894-017-0595-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
130 Beckers AB, Weerts ZZRM, Helyes Z, Masclee AAM, Keszthelyi D. Review article: transient receptor potential channels as possible therapeutic targets in irritable bowel syndrome. Aliment Pharmacol Ther 2017;46:938-52. [DOI: 10.1111/apt.14294] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
131 Hummel M, Knappenberger T, Reilly M, Whiteside GT. Pharmacological evaluation of NSAID-induced gastropathy as a "Translatable" model of referred visceral hypersensitivity. World J Gastroenterol 2017; 23(33): 6065-6076 [PMID: 28970722 DOI: 10.3748/wjg.v23.i33.6065] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
132 Bashashati M, Moossavi S, Cremon C, Barbaro MR, Moraveji S, Talmon G, Rezaei N, Hughes PA, Bian ZX, Choi CH, Lee OY, Coëffier M, Chang L, Ohman L, Schmulson MJ, Mccallum RW, Simren M, Sharkey KA, Barbara G. Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterol Motil 2018;30:e13192. [DOI: 10.1111/nmo.13192] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 15.6] [Reference Citation Analysis]
133 Khajavi N, Mergler S, Biebermann H. 3-Iodothyronamine, a Novel Endogenous Modulator of Transient Receptor Potential Melastatin 8? Front Endocrinol (Lausanne) 2017;8:198. [PMID: 28861042 DOI: 10.3389/fendo.2017.00198] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
134 Khajavi N, Mergler S, Biebermann H. 3-Iodothyronamine, a Novel Endogenous Modulator of Transient Receptor Potential Melastatin 8? Front Endocrinol 2017;8:198. [DOI: 10.3389/fendo.2017.00198] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
135 Bayer SB, Gearry RB, Drummond LN. Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function. Crit Rev Food Sci Nutr 2018;58:2432-52. [PMID: 28557573 DOI: 10.1080/10408398.2017.1327841] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
136 Kim Y, Kim JT, Park J, Son HJ, Kim EY, Lee YJ, Rhyu MR. 4,5-Di-O-Caffeoylquinic Acid from Ligularia fischeri Suppresses Inflammatory Responses Through TRPV1 Activation. Phytother Res 2017;31:1564-70. [PMID: 28782267 DOI: 10.1002/ptr.5885] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
137 Cheung CKY, Lan LL, Kyaw M, Mak ADP, Chan A, Chan Y, Wu JCY. Up-regulation of transient receptor potential vanilloid (TRPV) and down-regulation of brain-derived neurotrophic factor (BDNF) expression in patients with functional dyspepsia (FD). Neurogastroenterol Motil 2018;30. [PMID: 28782273 DOI: 10.1111/nmo.13176] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
138 Fabisiak A, Włodarczyk J, Fabisiak N, Storr M, Fichna J. Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal. J Neurogastroenterol Motil 2017;23:341-8. [PMID: 28551943 DOI: 10.5056/jnm16203] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
139 Brun P, Scarpa M, Marchiori C, Sarasin G, Caputi V, Porzionato A, Giron MC, Palù G, Castagliuolo I. Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS. PLoS One 2017;12:e0181863. [PMID: 28732069 DOI: 10.1371/journal.pone.0181863] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
140 Hsu LT, Hung KY, Wu HW, Liu WW, She MP, Lee TC, Sun CH, Yu WH, Buret AG, Yu LC. Gut-derived cholecystokinin contributes to visceral hypersensitivity via nerve growth factor-dependent neurite outgrowth. J Gastroenterol Hepatol. 2016;31:1594-1603. [PMID: 26773283 DOI: 10.1111/jgh.13296] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
141 Cozma-Petruţ A, Loghin F, Miere D, Dumitraşcu DL. Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients!. World J Gastroenterol 2017; 23(21): 3771-3783 [PMID: 28638217 DOI: 10.3748/wjg.v23.i21.3771] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 69] [Article Influence: 14.2] [Reference Citation Analysis]
142 Shen S, Al-Thumairy HW, Hashmi F, Qiao LY. Regulation of transient receptor potential cation channel subfamily V1 protein synthesis by the phosphoinositide 3-kinase/Akt pathway in colonic hypersensitivity. Exp Neurol 2017;295:104-15. [PMID: 28587873 DOI: 10.1016/j.expneurol.2017.06.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
143 Cearley SM, Immaneni S, Shankar P. Irritable Bowel Syndrome: The effect of FODMAPs and meditation on pain management. European Journal of Integrative Medicine 2017;12:117-21. [DOI: 10.1016/j.eujim.2017.05.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
144 Spiller R, Major G. IBS and IBD - separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol. 2016;13:613-621. [PMID: 27667579 DOI: 10.1038/nrgastro.2016.141] [Cited by in Crossref: 92] [Cited by in F6Publishing: 97] [Article Influence: 18.4] [Reference Citation Analysis]
145 Tsigaridas A, Papanikolaou IS, Vaiopoulou A, Anagnostopoulos AK, Viazis N, Karamanolis G, Karamanolis DG, Tsangaris GT, Mantzaris GJ, Gazouli M. Proteomics and irritable bowel syndrome. Expert Rev Proteomics 2017;14:461-8. [PMID: 28395553 DOI: 10.1080/14789450.2017.1317600] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
146 Balemans D, Boeckxstaens GE, Talavera K, Wouters MM. Transient receptor potential ion channel function in sensory transduction and cellular signaling cascades underlying visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol. 2017;312:G635-G648. [PMID: 28385695 DOI: 10.1152/ajpgi.00401.2016] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
147 Nakato R, Manabe N, Shimizu S, Hanayama K, Shiotani A, Hata J, Haruma K. Effects of Capsaicin on Older Patients with Oropharyngeal Dysphagia: A Double-Blind, Placebo-Controlled, Crossover Study. Digestion 2017;95:210-20. [DOI: 10.1159/000463382] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
148 Choi YJ, Kim N, Kim J, Lee DH, Park JH, Jung HC. Upregulation of Vanilloid Receptor-1 in Functional Dyspepsia With or Without Helicobacter pylori Infection. Medicine (Baltimore). 2016;95:e3410. [PMID: 27175641 DOI: 10.1097/md.0000000000003410] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
149 Schemann M. Reizdarm und Reizmagen – Pathophysiologie und Biomarker. Gastroenterologe 2017;12:114-29. [DOI: 10.1007/s11377-017-0143-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
150 Sood R, Gracie DJ, Gold MJ, To N, Pinto-Sanchez MI, Bercik P, Moayyedi P, Ford AC, Law GR. Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis. Aliment Pharmacol Ther 2017;45:824-32. [PMID: 28105700 DOI: 10.1111/apt.13949] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
151 Powell N, Walker MM, Talley NJ. The mucosal immune system: master regulator of bidirectional gut–brain communications. Nat Rev Gastroenterol Hepatol 2017;14:143-59. [DOI: 10.1038/nrgastro.2016.191] [Cited by in Crossref: 187] [Cited by in F6Publishing: 190] [Article Influence: 37.4] [Reference Citation Analysis]
152 El-chammas KI, Sood MR. Irritable Bowel Syndrome and Functional GI Disorders in Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_52] [Reference Citation Analysis]
153 Mosińska P, Krajewska J. Current Theories for Development of Irritable Bowel Syndrome. Introduction to Gastrointestinal Diseases Vol. 1 2017. [DOI: 10.1007/978-3-319-49016-8_1] [Reference Citation Analysis]
154 Lee KN, Lee OY. The Role of Mast Cells in Irritable Bowel Syndrome. Gastroenterol Res Pract. 2016;2016:2031480. [PMID: 28115927 DOI: 10.1155/2016/2031480] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
155 Jenkins FK. Spicy In Means Spicy Out: Capsaicin-Associated Anal Burn (CAAB) in Three US Metropolitan Populations, a New Proposed Classification System. JNHFE 2016;5. [DOI: 10.15406/jnhfe.2016.05.00183] [Reference Citation Analysis]
156 De Winter BY, Deiteren A, De Man JG. Novel nervous system mechanisms in visceral pain. Neurogastroenterol Motil 2016;28:309-15. [PMID: 26891060 DOI: 10.1111/nmo.12785] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
157 Reed DE, Vanner SJ. Emerging studies of human visceral nociceptors. Am J Physiol Gastrointest Liver Physiol 2017;312:G201-7. [PMID: 28007748 DOI: 10.1152/ajpgi.00391.2016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
158 Patcharatrakul T, Gonlachanvit S. Chili Peppers, Curcumins, and Prebiotics in Gastrointestinal Health and Disease. Curr Gastroenterol Rep 2016;18:19. [PMID: 26973345 DOI: 10.1007/s11894-016-0494-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
159 Li Q, Guo CH, Chowdhury MA, Dai TL, Han W. TRPA1 in the spinal dorsal horn is involved in post-inflammatory visceral hypersensitivity: in vivo study using TNBS-treated rat model. J Pain Res 2016;9:1153-60. [PMID: 27980434 DOI: 10.2147/JPR.S118581] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
160 Fourie NH, Peace RM, Abey SK, Sherwin LB, Wiley JW, Henderson WA. Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform. J Vis Exp 2016. [PMID: 27929459 DOI: 10.3791/54693] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
161 Faure C, Righini Grunder F. Visceral Sensitivity. In: Faure C, Thapar N, Di Lorenzo C, editors. Pediatric Neurogastroenterology. Cham: Springer International Publishing; 2017. pp. 39-52. [DOI: 10.1007/978-3-319-43268-7_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
162 Matsumoto K, Takagi K, Kato A, Ishibashi T, Mori Y, Tashima K, Mitsumoto A, Kato S, Horie S. Role of transient receptor potential melastatin 2 (TRPM2) channels in visceral nociception and hypersensitivity. Experimental Neurology 2016;285:41-50. [DOI: 10.1016/j.expneurol.2016.09.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
163 Farzaei MH, Bahramsoltani R, Abdollahi M, Rahimi R. The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments. J Neurogastroenterol Motil. 2016;22:558-574. [PMID: 27431236 DOI: 10.5056/jnm16001] [Cited by in Crossref: 104] [Cited by in F6Publishing: 104] [Article Influence: 17.3] [Reference Citation Analysis]
164 Nullens S, Deiteren A, Jiang W, Keating C, Ceuleers H, Francque S, Grundy D, De Man JG, De Winter BY. In Vitro Recording of Mesenteric Afferent Nerve Activity in Mouse Jejunal and Colonic Segments. J Vis Exp 2016. [PMID: 27805592 DOI: 10.3791/54576] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
165 Ahmad OF, Akbar A. Microbiome, antibiotics and irritable bowel syndrome. Br Med Bull 2016;120:91-9. [DOI: 10.1093/bmb/ldw038] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
166 Xu XJ, Liu L, Yao SK. Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target? J Zhejiang Univ Sci B. 2016;17:1-9. [PMID: 26739521 DOI: 10.1631/jzus.b1500181] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
167 Lauriello M, Eibenstein A, Angelone AM, Pasqua M, Tucci C, Di Giacomo C, Salerno A, Frieri G, Fusetti M. Association between vasomotor rhinitis and irritable bowel syndrome. Allergy Rhinol (Providence) 2016;7:249-55. [PMID: 28683253 DOI: 10.2500/ar.2016.7.0184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
168 Gebhart GF, Bielefeldt K. Physiology of Visceral Pain. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 1609-33. [DOI: 10.1002/cphy.c150049] [Cited by in Crossref: 101] [Cited by in F6Publishing: 105] [Article Influence: 16.8] [Reference Citation Analysis]
169 Lee Y, Jo J, Chung HY, Pothoulakis C, Im E. Endocannabinoids in the gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 2016;311:G655-66. [PMID: 27538961 DOI: 10.1152/ajpgi.00294.2015] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
170 Greenwood-van Meerveld B, Moloney RD, Johnson AC, Vicario M. Mechanisms of Stress-Induced Visceral Pain: Implications in Irritable Bowel Syndrome. J Neuroendocrinol 2016;28. [DOI: 10.1111/jne.12361] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
171 Fuentes IM, Walker NK, Pierce AN, Holt BR, Di Silvestro ER, Christianson JA. Neonatal maternal separation increases susceptibility to experimental colitis and acute stress exposure in male mice. IBRO Rep 2016;1:10-8. [PMID: 28164167 DOI: 10.1016/j.ibror.2016.07.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
172 Russo EB. Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes. Cannabis Cannabinoid Res 2016;1:154-65. [PMID: 28861491 DOI: 10.1089/can.2016.0009] [Cited by in Crossref: 87] [Cited by in F6Publishing: 93] [Article Influence: 14.5] [Reference Citation Analysis]
173 Fattori V, Hohmann MS, Rossaneis AC, Pinho-Ribeiro FA, Verri WA. Capsaicin: Current Understanding of Its Mechanisms and Therapy of Pain and Other Pre-Clinical and Clinical Uses. Molecules 2016;21:E844. [PMID: 27367653 DOI: 10.3390/molecules21070844] [Cited by in Crossref: 207] [Cited by in F6Publishing: 214] [Article Influence: 34.5] [Reference Citation Analysis]
174 Pierce AN, Zhang Z, Fuentes IM, Wang R, Ryals JM, Christianson JA. Neonatal vaginal irritation results in long-term visceral and somatic hypersensitivity and increased hypothalamic-pituitary-adrenal axis output in female mice. Pain 2015;156:2021-31. [PMID: 26098441 DOI: 10.1097/j.pain.0000000000000264] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
175 Brown JD, Saeed M, Do L, Braz J, Basbaum AI, Iadarola MJ, Wilson DM, Dillon WP. CT-guided injection of a TRPV1 agonist around dorsal root ganglia decreases pain transmission in swine. Sci Transl Med 2015;7:305ra145. [PMID: 26378245 DOI: 10.1126/scitranslmed.aac6589] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
176 McKenzie YA, Bowyer RK, Leach H, Gulia P, Horobin J, O'Sullivan NA, Pettitt C, Reeves LB, Seamark L, Williams M, Thompson J, Lomer MC; (IBS Dietetic Guideline Review Group on behalf of Gastroenterology Specialist Group of the British Dietetic Association). British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet 2016;29:549-75. [PMID: 27272325 DOI: 10.1111/jhn.12385] [Cited by in Crossref: 168] [Cited by in F6Publishing: 180] [Article Influence: 28.0] [Reference Citation Analysis]
177 Olesen AE, Farmer AD, Olesen SS, Aziz Q, Drewes AM. Management of chronic visceral pain. Pain Manag 2016;6:469-86. [PMID: 27256577 DOI: 10.2217/pmt-2015-0011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
178 Luo Y, Feng C, Wu J, Wu Y, Liu D, Wu J, Dai F, Zhang J. P2Y1, P2Y2, and TRPV1 Receptors Are Increased in Diarrhea-Predominant Irritable Bowel Syndrome and P2Y2 Correlates with Abdominal Pain. Dig Dis Sci. 2016;61:2878-2886. [PMID: 27250983 DOI: 10.1007/s10620-016-4211-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
179 Zhou Q, Yang L, Larson S, Basra S, Merwat S, Tan A, Croce C, Verne GN. Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1. Gut 2016;65:797-805. [PMID: 25681400 DOI: 10.1136/gutjnl-2013-306464] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 12.8] [Reference Citation Analysis]
180 Spiller R. Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Res 2016;5:F1000 Faculty Rev-780. [PMID: 27158477 DOI: 10.12688/f1000research.7992.1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
181 Loewendorf AI, Matynia A, Saribekyan H, Gross N, Csete M, Harrington M. Roads Less Traveled: Sexual Dimorphism and Mast Cell Contributions to Migraine Pathology. Front Immunol 2016;7:140. [PMID: 27148260 DOI: 10.3389/fimmu.2016.00140] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
182 Lee SY, Masaoka T, Han HS, Matsuzaki J, Hong MJ, Fukuhara S, Choi HS, Suzuki H. A prospective study on symptom generation according to spicy food intake and TRPV1 genotypes in functional dyspepsia patients. Neurogastroenterol Motil. 2016;28:1401-1408. [PMID: 27094759 DOI: 10.1111/nmo.12841] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
183 Mansour MA, Sabbah NA, Mansour SA, Ibrahim AM. MicroRNA-199b expression level and coliform count in irritable bowel syndrome. IUBMB Life. 2016;68:335-342. [PMID: 27015896 DOI: 10.1002/iub.1495] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
184 Barshop K, Staller K. New Pathways, New Targets: Visceral Hypersensitivity Pathogenesis in Irritable Bowel Syndrome. Clin Transl Gastroenterol. 2016;7:e146. [PMID: 26913769 DOI: 10.1038/ctg.2016.12] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
185 Sinagra E, Pompei G, Tomasello G, Cappello F, Morreale GC, Amvrosiadis G, Rossi F, Lo Monte AI, Rizzo AG, Raimondo D. Inflammation in irritable bowel syndrome: Myth or new treatment target? World J Gastroenterol 2016; 22(7): 2242-2255 [PMID: 26900287 DOI: 10.3748/wjg.v22.i7.2242] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 65] [Article Influence: 9.8] [Reference Citation Analysis]
186 Teruel C, Garrido E, Mesonero F. Diagnosis and management of functional symptoms in inflammatory bowel disease in remission. World J Gastrointest Pharmacol Ther 2016; 7(1): 78-90 [PMID: 26855814 DOI: 10.4292/wjgpt.v7.i1.78] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
187 Wang P, Du C, Chen FX, Li CQ, Yu YB, Han T, Akhtar S, Zuo XL, Tan XD, Li YQ. BDNF contributes to IBS-like colonic hypersensitivity via activating the enteroglia-nerve unit. Sci Rep. 2016;6:20320. [PMID: 26837784 DOI: 10.1038/srep20320] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 6.8] [Reference Citation Analysis]
188 Keating C, Nocchi L, Yu Y, Donovan J, Grundy D. Ageing and gastrointestinal sensory function: altered colonic mechanosensory and chemosensory function in the aged mouse. J Physiol 2016;594:4549-64. [PMID: 26592729 DOI: 10.1113/JP271403] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
189 Bennet SM, Ohman L, Simren M. Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver. 2015;9:318-331. [PMID: 25918261 DOI: 10.5009/gnl14344] [Cited by in Crossref: 88] [Cited by in F6Publishing: 92] [Article Influence: 14.7] [Reference Citation Analysis]
190 Johnson AC, Greenwood-Van Meerveld B. The Pharmacology of Visceral Pain. Adv Pharmacol 2016;75:273-301. [PMID: 26920016 DOI: 10.1016/bs.apha.2015.11.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
191 Quigley EM. Probiotics, Prebiotics, Synbiotics, and Other Strategies to Modulate the Gut Microbiota in Irritable Bowel Syndrome (IBS). Probiotics, Prebiotics, and Synbiotics 2016. [DOI: 10.1016/b978-0-12-802189-7.00039-3] [Reference Citation Analysis]
192 Wouters MM, Vicario M, Santos J. The role of mast cells in functional GI disorders. Gut 2016;65:155-68. [PMID: 26194403 DOI: 10.1136/gutjnl-2015-309151] [Cited by in Crossref: 191] [Cited by in F6Publishing: 198] [Article Influence: 31.8] [Reference Citation Analysis]
193 Aich A, Afrin LB, Gupta K. Mast Cell-Mediated Mechanisms of Nociception. Int J Mol Sci 2015;16:29069-92. [PMID: 26690128 DOI: 10.3390/ijms161226151] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 12.0] [Reference Citation Analysis]
194 Shinoda M, Takeda M, Honda K, Maruno M, Katagiri A, Satoh-kuriwada S, Shoji N, Tsuchiya M, Iwata K. Involvement of peripheral artemin signaling in tongue pain: possible mechanism in burning mouth syndrome. Pain 2015;156:2528-37. [DOI: 10.1097/j.pain.0000000000000322] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
195 Videlock EJ, Chang L. Irritable Bowel Syndrome. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch75] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
196 Farmer AD, Aziz Q. Gut pain & visceral hypersensitivity. Br J Pain. 2013;7:39-47. [PMID: 26516496 DOI: 10.1177/2049463713479229] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
197 Zhenzhong L, Xiaojun Y, Weijun T, Yuehua C, Jie S, Jimeng Z, Anqi W, Chunhui B, Yin S. Comparative effect of electroacupuncture and moxibustion on the expression of substance P and vasoactive intestinal peptide in patients with irritable bowel syndrome. J Tradit Chin Med 2015;35:402-10. [PMID: 26427109 DOI: 10.1016/s0254-6272(15)30116-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
198 Yu X, Yu M, Liu Y, Yu S. TRP channel functions in the gastrointestinal tract. Semin Immunopathol. 2016;38:385-396. [PMID: 26459157 DOI: 10.1007/s00281-015-0528-y] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 6.6] [Reference Citation Analysis]
199 Bradesi S. Mechanistic understanding of the effects of probiotics in the modulation of abdominal pain: one study at a time. J Physiol 2015;593:3769-70. [PMID: 26331831 DOI: 10.1113/JP271121] [Reference Citation Analysis]
200 Itomi Y, Kawamura T, Tsukimi Y. Specific alteration of rhythm in temperature-stressed rats possess features of abdominal pain in IBS patients. Journal of Pharmacological Sciences 2015;129:26-30. [DOI: 10.1016/j.jphs.2015.07.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
201 Perez-Burgos A, Wang L, McVey Neufeld KA, Mao YK, Ahmadzai M, Janssen LJ, Stanisz AM, Bienenstock J, Kunze WA. The TRPV1 channel in rodents is a major target for antinociceptive effect of the probiotic Lactobacillus reuteri DSM 17938. J Physiol. 2015;593:3943-3957. [PMID: 26084409 DOI: 10.1113/jp270229] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 10.6] [Reference Citation Analysis]
202 Deberry JJ, Bielefeldt K, Davis BM, Szigethy EM, Hartman DJ, Coates MD. Abdominal pain and the neurotrophic system in ulcerative colitis. Inflamm Bowel Dis. 2014;20:2330-2339. [PMID: 25358061 DOI: 10.1097/mib.0000000000000207] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
203 Feng Q. Temperature sensing by thermal TRP channels: thermodynamic basis and molecular insights. Curr Top Membr 2014;74:19-50. [PMID: 25366232 DOI: 10.1016/B978-0-12-800181-3.00002-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
204 Jonefjäll B, Simrén M, Öhman L, Lasson A, Svedlund J, Strid H. The severity of inflammation at onset of ulcerative colitis is not associated with IBS-like symptoms during clinical remission. ECCOJC 2015;9:776-83. [DOI: 10.1093/ecco-jcc/jjv107] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
205 Evangelista S. Novel therapeutics in the field of capsaicin and pain. Expert Review of Clinical Pharmacology 2015;8:373-5. [DOI: 10.1586/17512433.2015.1044438] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
206 Capasso R, Orlando P, Pagano E, Aveta T, Buono L, Borrelli F, Di Marzo V, Izzo AA. Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1 channels. Br J Pharmacol. 2014;171:4026-4037. [PMID: 24818658 DOI: 10.1111/bph.12759] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 9.9] [Reference Citation Analysis]
207 Shi HL, Liu CH, Ding LL, Zheng Y, Fei XY, Lu L, Zhou XM, Yuan JY, Xie JQ. Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction. World J Gastroenterol 2015; 21(16): 4852-4863 [PMID: 25944998 DOI: 10.3748/wjg.v21.i16.4852] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
208 Hungin AP, Becher A, Cayley B, Heidelbaugh JJ, Muris JW, Rubin G, Seifert B, Russell A, De Wit NJ. Irritable bowel syndrome: an integrated explanatory model for clinical practice. Neurogastroenterol Motil 2015;27:750-63. [PMID: 25703486 DOI: 10.1111/nmo.12524] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
209 Dothel G, Barbaro MR, Boudin H, Vasina V, Cremon C, Gargano L, Bellacosa L, De Giorgio R, Le Berre-Scoul C, Aubert P, Neunlist M, De Ponti F, Stanghellini V, Barbara G. Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology. 2015;148:1002-1011.e4. [PMID: 25655556 DOI: 10.1053/j.gastro.2015.01.042] [Cited by in Crossref: 109] [Cited by in F6Publishing: 112] [Article Influence: 15.6] [Reference Citation Analysis]
210 Laing RJ, Dhaka A. ThermoTRPs and Pain. Neuroscientist 2016;22:171-87. [PMID: 25608689 DOI: 10.1177/1073858414567884] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 8.6] [Reference Citation Analysis]
211 Bishnoi M, Khare P, Kondepudi KK, Premkumar LS. The Role of TRPV1 in Acquired Diseases. TRP Channels as Therapeutic Targets 2015. [DOI: 10.1016/b978-0-12-420024-1.00003-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
212 Poole DP, Lieu T, Veldhuis NA, Rajasekhar P, Bunnett NW. Targeting of Transient Receptor Potential Channels in Digestive Disease. TRP Channels as Therapeutic Targets 2015. [DOI: 10.1016/b978-0-12-420024-1.00021-7] [Reference Citation Analysis]
213 Kaneko Y, Szallasi A. Transient receptor potential (TRP) channels: a clinical perspective. Br J Pharmacol 2014;171:2474-507. [PMID: 24102319 DOI: 10.1111/bph.12414] [Cited by in Crossref: 234] [Cited by in F6Publishing: 246] [Article Influence: 29.3] [Reference Citation Analysis]
214 Öhman L, Törnblom H, Simrén M. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS. Nat Rev Gastroenterol Hepatol 2015;12:36-49. [DOI: 10.1038/nrgastro.2014.200] [Cited by in Crossref: 125] [Cited by in F6Publishing: 131] [Article Influence: 15.6] [Reference Citation Analysis]
215 Caviglia GP, Pantaleoni S, Touscoz GA, Adriani A, Rosso C, Smedile A, Pellicano R, Astegiano M, Bresso F. Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders. Scand J Gastroenterol. 2014;49:1419-1424. [PMID: 25369978 DOI: 10.3109/00365521.2014.934913] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 5.5] [Reference Citation Analysis]
216 Yoshikawa S, Kawamorita N, Oguchi T, Funahashi Y, Tyagi P, Chancellor MB, Yoshimura N. Pelvic organ cross-sensitization to enhance bladder and urethral pain behaviors in rats with experimental colitis. Neuroscience 2015;284:422-9. [PMID: 25445197 DOI: 10.1016/j.neuroscience.2014.08.064] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
217 Kun J, Szitter I, Kemény A, Perkecz A, Kereskai L, Pohóczky K, Vincze A, Gódi S, Szabó I, Szolcsányi J, Pintér E, Helyes Z. Upregulation of the transient receptor potential ankyrin 1 ion channel in the inflamed human and mouse colon and its protective roles. PLoS One 2014;9:e108164. [PMID: 25265225 DOI: 10.1371/journal.pone.0108164] [Cited by in Crossref: 85] [Cited by in F6Publishing: 87] [Article Influence: 10.6] [Reference Citation Analysis]
218 Hong S, Zheng G, Wiley JW. Epigenetic regulation of genes that modulate chronic stress-induced visceral pain in the peripheral nervous system. Gastroenterology 2015;148:148-157.e7. [PMID: 25263804 DOI: 10.1053/j.gastro.2014.09.032] [Cited by in Crossref: 84] [Cited by in F6Publishing: 89] [Article Influence: 10.5] [Reference Citation Analysis]
219 Devesa I, Ferrer-Montiel A. Neurotrophins, endocannabinoids and thermo-transient receptor potential: a threesome in pain signalling. Eur J Neurosci 2014;39:353-62. [PMID: 24494676 DOI: 10.1111/ejn.12455] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
220 Badizadegan K, Thomas AR, Nagy N, Ndishabandi D, Miller SA, Alessandrini A, Belkind-Gerson J, Goldstein AM. Presence of intramucosal neuroglial cells in normal and aganglionic human colon. Am J Physiol Gastrointest Liver Physiol 2014;307:G1002-12. [PMID: 25214400 DOI: 10.1152/ajpgi.00164.2014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
221 Liu Y, Liu W, Peng QX, Peng JL, Yu LZ, Hu JL. Protective effect of huoxiang zhengqi oral liquid on intestinal mucosal mechanical barrier of rats with postinfectious irritable bowel syndrome induced by acetic Acid. Evid Based Complement Alternat Med. 2014;2014:218383. [PMID: 25254052 DOI: 10.1155/2014/218383] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
222 Keszthelyi D, Masclee A. Capsaicin Stimulation In Irritable Bowel Syndrome: Toward Understanding Visceral Perception and Pain Symptom Generation. American Journal of Gastroenterology 2014;109:1286-1286. [DOI: 10.1038/ajg.2014.135] [Reference Citation Analysis]
223 Sood R, Law GR, Ford AC. Diagnosis of IBS: symptoms, symptom-based criteria, biomarkers or 'psychomarkers'? Nat Rev Gastroenterol Hepatol. 2014;11:683-691. [PMID: 25069544 DOI: 10.1038/nrgastro.2014.127] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
224 Choi YJ, Hwang SW, Kim N, Park JH, Oh JC, Lee DH. Association Between SLC6A4 Serotonin Transporter Gene Lainked Polymorphic Region and ADRA2A -1291C>G and Irritable Bowel Syndrome in Korea. J Neurogastroenterol Motil. 2014;20:388-399. [PMID: 24917480 DOI: 10.5056/jnm14020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
225 Aniwan S, Gonlachanvit S. Effects of Chili Treatment on Gastrointestinal and Rectal Sensation in Diarrhea-predominant Irritable Bowel Syndrome: A Randomized, Double-blinded, Crossover Study. J Neurogastroenterol Motil 2014;20:400-6. [PMID: 24867591 DOI: 10.5056/jnm14022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
226 Evangelista S. Capsaicin receptor as target of calcitonin gene-related peptide in the gut. Prog Drug Res 2014;68:259-76. [PMID: 24941672 DOI: 10.1007/978-3-0348-0828-6_10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
227 Muscatello MRA, Bruno A, Scimeca G, Pandolfo G, Zoccali RA. Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome. World J Gastroenterol 2014; 20(24): 7570-7586 [PMID: 24976697 DOI: 10.3748/wjg.v20.i24.7570] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
228 Nilius B, Szallasi A, Sibley DR. Transient Receptor Potential Channels as Drug Targets: From the Science of Basic Research to the Art of Medicine. Pharmacol Rev 2014;66:676-814. [DOI: 10.1124/pr.113.008268] [Cited by in Crossref: 338] [Cited by in F6Publishing: 348] [Article Influence: 42.3] [Reference Citation Analysis]
229 Frieling T, Schemann M. Reizdarmsyndrom – Epidemiologie und Pathophysiologie. coloproctology 2014;36:181-189. [DOI: 10.1007/s00053-014-0435-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
230 Furuta A, Suzuki Y, Naruoka T, Asano K, Egawa S, Yoshimura N. Cross-sensitization mechanisms between colon and bladder via transient receptor potential A1 stimulation in rats. Int Urogynecol J 2014;25:1575-81. [PMID: 24828604 DOI: 10.1007/s00192-014-2405-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
231 Van Gerven L, Alpizar YA, Wouters MM, Hox V, Hauben E, Jorissen M, Boeckxstaens G, Talavera K, Hellings PW. Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis. Journal of Allergy and Clinical Immunology 2014;133:1332-1339.e3. [DOI: 10.1016/j.jaci.2013.08.026] [Cited by in Crossref: 77] [Cited by in F6Publishing: 68] [Article Influence: 9.6] [Reference Citation Analysis]
232 Park SW, Lee H, Lee HJ, Chung H, Park JC, Shin SK, Lee SK, Lee YC. Esophageal mucosal mast cell infiltration and changes in segmental smooth muscle contraction in noncardiac chest pain. Dis Esophagus 2015;28:512-9. [PMID: 24766344 DOI: 10.1111/dote.12231] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
233 Neri M. Irritable bowel syndrome, inflammatory bowel disease and TRPV1: how to disentangle the bundle. Eur J Pain. 2013;17:1263-1264. [PMID: 24006367 DOI: 10.1002/j.1532-2149.2013.00345.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
234 Farmer AD, Aziz Q. Mechanisms of visceral pain in health and functional gastrointestinal disorders. Scand J Pain 2014;5:51-60. [PMID: 29913680 DOI: 10.1016/j.sjpain.2014.01.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
235 Lee YJ, Park KS. Irritable bowel syndrome: Emerging paradigm in pathophysiology. World J Gastroenterol 2014; 20(10): 2456-2469 [PMID: 24627583 DOI: 10.3748/wjg.v20.i10.2456] [Cited by in CrossRef: 88] [Cited by in F6Publishing: 95] [Article Influence: 11.0] [Reference Citation Analysis]
236 de Fontgalland D, Brookes SJ, Gibbins I, Sia TC, Wattchow DA. The neurochemical changes in the innervation of human colonic mesenteric and submucosal blood vessels in Ulcerative colitis and Crohn's disease. Neurogastroenterol Motil 2014;26:731-44. [DOI: 10.1111/nmo.12327] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
237 Bourinet E, Altier C, Hildebrand ME, Trang T, Salter MW, Zamponi GW. Calcium-permeable ion channels in pain signaling. Physiol Rev 2014;94:81-140. [PMID: 24382884 DOI: 10.1152/physrev.00023.2013] [Cited by in Crossref: 199] [Cited by in F6Publishing: 206] [Article Influence: 24.9] [Reference Citation Analysis]
238 Nasser Y, Boeckxstaens GE, Wouters MM, Schemann M, Vanner S. Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome. Neurogastroenterol Motil. 2014;26:455-469. [PMID: 24602069 DOI: 10.1111/nmo.12316] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
239 Serra J, Collado A, Solà R, Antonelli F, Torres X, Salgueiro M, Quiles C, Bostock H. Hyperexcitable C nociceptors in fibromyalgia: C Nociceptors in Fibromyalgia. Ann Neurol 2014;75:196-208. [DOI: 10.1002/ana.24065] [Cited by in Crossref: 170] [Cited by in F6Publishing: 179] [Article Influence: 21.3] [Reference Citation Analysis]
240 Alvarez-Berdugo D, Jiménez M, Clavé P, Rofes L. Pharmacodynamics of TRPV1 agonists in a bioassay using human PC-3 cells. ScientificWorldJournal 2014;2014:184526. [PMID: 24688365 DOI: 10.1155/2014/184526] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
241 Vermeulen W, Man JGD, Pelckmans PA, Winter BYD. Neuroanatomy of lower gastrointestinal pain disorders. World J Gastroenterol 2014; 20(4): 1005-1020 [PMID: 24574773 DOI: 10.3748/wjg.v20.i4.1005] [Cited by in CrossRef: 74] [Cited by in F6Publishing: 78] [Article Influence: 9.3] [Reference Citation Analysis]
242 Pierce AN, Ryals JM, Wang R, Christianson JA. Vaginal hypersensitivity and hypothalamic-pituitary-adrenal axis dysfunction as a result of neonatal maternal separation in female mice. Neuroscience 2014;263:216-30. [PMID: 24462609 DOI: 10.1016/j.neuroscience.2014.01.022] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
243 Denadai-souza A, Cenac N. Transient Receptor Potential Channels and Pain. Pathologies of Calcium Channels 2014. [DOI: 10.1007/978-3-642-40282-1_20] [Reference Citation Analysis]
244 Fong IW. Irritable Bowel Syndrome and Microbial Pathogenesis. The Role of Microbes in Common Non-Infectious Diseases 2014. [DOI: 10.1007/978-1-4939-1670-2_1] [Reference Citation Analysis]
245 Shang JJ, Yuan JY, Xu H, Tang RZ, Dong YB, Xie JQ. Shugan-decoction relieves visceral hyperalgesia and reduces TRPV1 and SP colon expression. World J Gastroenterol 2013; 19(44): 8071-8077 [PMID: 24307802 DOI: 10.3748/wjg.v19.i44.8071] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
246 Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, Yoon BC, Choi HS, Sim J, Jang KS. Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea. Scand J Gastroenterol. 2014;49:43-51. [PMID: 24256141 DOI: 10.3109/00365521.2013.857712] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
247 Di Nardo G, Barbara G, Cucchiara S, Cremon C, Shulman RJ, Isoldi S, Zecchi L, Drago L, Oliva S, Saulle R. Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS. Neurogastroenterol Motil. 2014;26:196-204. [PMID: 24304324 DOI: 10.1111/nmo.12250] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
248 van Wanrooij SJ, Wouters MM, Van Oudenhove L, Vanbrabant W, Mondelaers S, Kollmann P, Kreutz F, Schemann M, Boeckxstaens GE. Sensitivity testing in irritable bowel syndrome with rectal capsaicin stimulations: role of TRPV1 upregulation and sensitization in visceral hypersensitivity? Am J Gastroenterol. 2014;109:99-109. [PMID: 24189713 DOI: 10.1038/ajg.2013.371] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 7.7] [Reference Citation Analysis]
249 Sharma SK, Vij AS, Sharma M. Mechanisms and clinical uses of capsaicin. European Journal of Pharmacology 2013;720:55-62. [DOI: 10.1016/j.ejphar.2013.10.053] [Cited by in Crossref: 176] [Cited by in F6Publishing: 186] [Article Influence: 19.6] [Reference Citation Analysis]
250 Dai C, Zheng CQ, Jiang M, Ma XY, Jiang LJ. Probiotics and irritable bowel syndrome. World J Gastroenterol 2013; 19(36): 5973-5980 [PMID: 24106397 DOI: 10.3748/wjg.v19.i36.5973] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
251 Scalera A, Di Minno MND, Tarantino G. What does irritable bowel syndrome share with non-alcoholic fatty liver disease? World J Gastroenterol 2013; 19(33): 5402-5420 [PMID: 24023483 DOI: 10.3748/wjg.v19.i33.5402] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
252 Frieling T, Schemann M. Reizdarmsyndrom – Epidemiologie und Pathophysiologie. Gastroenterologe 2013;8:405-16. [DOI: 10.1007/s11377-013-0782-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
253 Kiyatkin ME, Feng B, Schwartz ES, Gebhart GF. Combined genetic and pharmacological inhibition of TRPV1 and P2X3 attenuates colorectal hypersensitivity and afferent sensitization. Am J Physiol Gastrointest Liver Physiol 2013;305:G638-48. [PMID: 23989007 DOI: 10.1152/ajpgi.00180.2013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
254 Valdez-Morales EE, Overington J, Guerrero-Alba R, Ochoa-Cortes F, Ibeakanma CO, Spreadbury I, Bunnett NW, Beyak M, Vanner SJ. Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2. Am J Gastroenterol. 2013;108:1634-1643. [PMID: 23958521 DOI: 10.1038/ajg.2013.241] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 8.2] [Reference Citation Analysis]
255 Trevisan G, Rossato MF, Hoffmeister C, Oliveira SM, Silva CR, Matheus FC, Mello GC, Antunes E, Prediger RD, Ferreira J. Mechanisms involved in abdominal nociception induced by either TRPV1 or TRPA1 stimulation of rat peritoneum. Eur J Pharmacol 2013;714:332-44. [PMID: 23911956 DOI: 10.1016/j.ejphar.2013.07.029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
256 Matricon J, Muller E, Accarie A, Meleine M, Etienne M, Voilley N, Busserolles J, Eschalier A, Lazdunski M, Bourdu S. Peripheral contribution of NGF and ASIC1a to colonic hypersensitivity in a rat model of irritable bowel syndrome. Neurogastroenterol Motil. 2013;25:e740-e754. [PMID: 23902154 DOI: 10.1111/nmo.12199] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
257 Ringel Y, Maharshak N. Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2013;305:G529-G541. [PMID: 23886861 DOI: 10.1152/ajpgi.00207.2012] [Cited by in Crossref: 77] [Cited by in F6Publishing: 84] [Article Influence: 8.6] [Reference Citation Analysis]
258 Paltser G, Liu XJ, Yantha J, Winer S, Tsui H, Wu P, Maezawa Y, Cahill LS, Laliberté CL, Ramagopalan SV, DeLuca GC, Sadovnick AD, Astsaturov I, Ebers GC, Henkelman RM, Salter MW, Dosch HM. TRPV1 gates tissue access and sustains pathogenicity in autoimmune encephalitis. Mol Med 2013;19:149-59. [PMID: 23689362 DOI: 10.2119/molmed.2012.00329] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
259 Zhuang LL, Hu TM. Advances in understanding the relationship between inflammatory immune response and irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2013; 21(20): 1950-1954 [DOI: 10.11569/wcjd.v21.i20.1950] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
260 Hoffman JM. Irritable bowel syndrome: is the colonic mucosa to blame? Neurogastroenterol Motil 2012;24:1051-3. [PMID: 23176660 DOI: 10.1111/nmo.12039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
261 Gao J. Correlation between anxiety-depression status and cytokines in diarrhea-predominant irritable bowel syndrome. Exp Ther Med. 2013;6:93-96. [PMID: 23935726 DOI: 10.3892/etm.2013.1101] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
262 Durall PS, Clark GT. Burning Mouth Syndrome: An Update on Diagnosis and Treatment Methods. Orofacial Pain 2013. [DOI: 10.1002/9781118704851.ch14] [Reference Citation Analysis]
263 Hughes PA, Zola H, Penttila IA, Blackshaw LA, Andrews JM, Krumbiegel D. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms? Am J Gastroenterol. 2013;108:1066-1074. [PMID: 23649183 DOI: 10.1038/ajg.2013.120] [Cited by in Crossref: 110] [Cited by in F6Publishing: 111] [Article Influence: 12.2] [Reference Citation Analysis]
264 Ramachandran R, Hyun E, Zhao L, Lapointe TK, Chapman K, Hirota CL, Ghosh S, McKemy DD, Vergnolle N, Beck PL, Altier C, Hollenberg MD. TRPM8 activation attenuates inflammatory responses in mouse models of colitis. Proc Natl Acad Sci U S A 2013;110:7476-81. [PMID: 23596210 DOI: 10.1073/pnas.1217431110] [Cited by in Crossref: 105] [Cited by in F6Publishing: 115] [Article Influence: 11.7] [Reference Citation Analysis]
265 Belfer I, Shnol H, Finelli P. Molecular Genetics of Variability in Human Pain. eLS 2013. [DOI: 10.1002/9780470015902.a0024443] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
266 Farmer AD, Peiris M, Aziz Q. Gut Hypersensitivity Related Symptoms. Irritable Bowel Syndrome 2013. [DOI: 10.1002/9781118444689.ch12] [Reference Citation Analysis]
267 Keszthelyi D, Troost FJ, Jonkers DM, Helyes Z, Hamer HM, Ludidi S, Vanhoutvin S, Venema K, Dekker J, Szolcsányi J. Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation? Eur J Pain. 2013;17:1299-1306. [PMID: 23529955 DOI: 10.1002/j.1532-2149.2013.00309.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
268 Brookes SJ, Spencer NJ, Costa M, Zagorodnyuk VP. Extrinsic primary afferent signalling in the gut. Nat Rev Gastroenterol Hepatol. 2013;10:286-296. [PMID: 23438947 DOI: 10.1038/nrgastro.2013.29] [Cited by in Crossref: 173] [Cited by in F6Publishing: 180] [Article Influence: 19.2] [Reference Citation Analysis]
269 El-chammas KI, Sood MR. Irritable Bowel Syndrome and Functional Gastrointestinal Disorders in Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2013. [DOI: 10.1007/978-1-4614-5061-0_46] [Reference Citation Analysis]
270 Faure C. Visceral Sensitivity. Pediatric Neurogastroenterology 2013. [DOI: 10.1007/978-1-60761-709-9_4] [Reference Citation Analysis]
271 Bortolotti M. Red pepper: an aid for gut functional diseases with pain? Ann Gastroenterol 2013;26:276. [PMID: 24714314] [Reference Citation Analysis]
272 Anand U, Facer P, Yiangou Y, Sinisi M, Fox M, McCarthy T, Bountra C, Korchev YE, Anand P. Angiotensin II type 2 receptor (AT2 R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons. Eur J Pain 2013;17:1012-26. [PMID: 23255326 DOI: 10.1002/j.1532-2149.2012.00269.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 78] [Article Influence: 7.1] [Reference Citation Analysis]
273 Li X, Cao Y, Wong RK, Ho KY, Wilder-Smith CH. Visceral and somatic sensory function in functional dyspepsia. Neurogastroenterol Motil. 2013;25:246-253, e165. [PMID: 23171089 DOI: 10.1111/nmo.12044] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
274 Matricon J, Meleine M, Gelot A, Piche T, Dapoigny M, Muller E, Ardid D. Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther 2012;36:1009-31. [DOI: 10.1111/apt.12080] [Cited by in Crossref: 140] [Cited by in F6Publishing: 155] [Article Influence: 14.0] [Reference Citation Analysis]
275 Chen WH, Tzen JT, Hsieh CL, Chen YH, Lin TJ, Chen SY, Lin YW. Attenuation of TRPV1 and TRPV4 Expression and Function in Mouse Inflammatory Pain Models Using Electroacupuncture. Evid Based Complement Alternat Med 2012;2012:636848. [PMID: 23258994 DOI: 10.1155/2012/636848] [Cited by in Crossref: 17] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
276 Wang SJ, Yang HY, Xu GS. Acupuncture Alleviates Colorectal Hypersensitivity and Correlates with the Regulatory Mechanism of TrpV1 and p-ERK. Evid Based Complement Alternat Med 2012;2012:483123. [PMID: 23097675 DOI: 10.1155/2012/483123] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
277 Benson S, Engler H, Schedlowski M, Elsenbruch S. Experimental endotoxemia as a model to study neuroimmune mechanisms in human visceral pain. Ann N Y Acad Sci 2012;1262:108-17. [PMID: 22823442 DOI: 10.1111/j.1749-6632.2012.06622.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
278 Schicho R, Storr M. Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies. Expert Rev Clin Pharmacol 2010;3:193-207. [PMID: 22111567 DOI: 10.1586/ecp.09.62] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
279 Ramsden CE, Ringel A, Feldstein AE, Taha AY, MacIntosh BA, Hibbeln JR, Majchrzak-Hong SF, Faurot KR, Rapoport SI, Cheon Y. Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans. Prostaglandins Leukot Essent Fatty Acids. 2012;87:135-141. [PMID: 22959954 DOI: 10.1016/j.plefa.2012.08.004] [Cited by in Crossref: 127] [Cited by in F6Publishing: 115] [Article Influence: 12.7] [Reference Citation Analysis]
280 Balestra B, Vicini R, Cremon C, Zecchi L, Dothel G, Vasina V, De Giorgio R, Paccapelo A, Pastoris O, Stanghellini V. Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons. Neurogastroenterol Motil. 2012;24:e1118-e1570. [PMID: 22937879 DOI: 10.1111/nmo.12000] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
281 Barrett JS, Gibson PR. Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals? Therap Adv Gastroenterol. 2012;5:261-268. [PMID: 22778791 DOI: 10.1177/1756283x11436241] [Cited by in Crossref: 95] [Cited by in F6Publishing: 102] [Article Influence: 9.5] [Reference Citation Analysis]
282 Camilleri M, Lasch K, Zhou W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;303:G775-G785. [PMID: 22837345 DOI: 10.1152/ajpgi.00155.2012] [Cited by in Crossref: 228] [Cited by in F6Publishing: 256] [Article Influence: 22.8] [Reference Citation Analysis]
283 Spiller R, Lam C. An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. J Neurogastroenterol Motil. 2012;18:258-268. [PMID: 22837873 DOI: 10.5056/jnm.2012.18.3.258] [Cited by in Crossref: 104] [Cited by in F6Publishing: 115] [Article Influence: 10.4] [Reference Citation Analysis]
284 Sikandar S, Dickenson AH. Visceral pain: the ins and outs, the ups and downs. Curr Opin Support Palliat Care. 2012;6:17-26. [PMID: 22246042 DOI: 10.1097/spc.0b013e32834f6ec9] [Cited by in Crossref: 121] [Cited by in F6Publishing: 131] [Article Influence: 12.1] [Reference Citation Analysis]
285 Nash MS, Mcintyre P, Groarke A, Lilley E, Culshaw A, Hallett A, Panesar M, Fox A, Bevan S. 7- tert -Butyl-6-(4-Chloro-Phenyl)-2-Thioxo-2,3-Dihydro-1 H -Pyrido[2,3- d ]Pyrimidin-4-One, a Classic Polymodal Inhibitor of Transient Receptor Potential Vanilloid Type 1 with a Reduced Liability for Hyperthermia, Is Analgesic and Ameliorates Visceral Hypersensitivity. J Pharmacol Exp Ther 2012;342:389-98. [DOI: 10.1124/jpet.112.191932] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
286 Jimenez-Andrade JM, Mantyh PW. Sensory and sympathetic nerve fibers undergo sprouting and neuroma formation in the painful arthritic joint of geriatric mice. Arthritis Res Ther. 2012;14:R101. [PMID: 22548760 DOI: 10.1186/ar3826] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 7.3] [Reference Citation Analysis]
287 Keszthelyi D, Troost F, Simrén M, Ludidi S, Kruimel J, Conchillo J, Masclee A. Revisiting concepts of visceral nociception in irritable bowel syndrome: Visceronociception in irritable bowel syndrome. EJP 2012;16:1444-54. [DOI: 10.1002/j.1532-2149.2012.00147.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
288 Gibson PR, Shepherd SJ. Food choice as a key management strategy for functional gastrointestinal symptoms. Am J Gastroenterol. 2012;107:657-66; quiz 667. [PMID: 22488077 DOI: 10.1038/ajg.2012.49] [Cited by in Crossref: 133] [Cited by in F6Publishing: 137] [Article Influence: 13.3] [Reference Citation Analysis]
289 Braak B, Klooker TK, Wouters MM, Welting O, van der Loos CM, Stanisor OI, van Diest S, van den Wijngaard RM, Boeckxstaens GE. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship? Am J Gastroenterol. 2012;107:715-726. [PMID: 22488080 DOI: 10.1038/ajg.2012.54] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 6.3] [Reference Citation Analysis]
290 Furuta A, Suzuki Y, Hayashi N, Egawa S, Yoshimura N. Transient receptor potential A1 receptor-mediated neural cross-talk and afferent sensitization induced by oxidative stress: Implication for the pathogenesis of interstitial cystitis/bladder pain syndrome: TRPA1 receptor and interstitial cystitis. International Journal of Urology 2012;19:429-36. [DOI: 10.1111/j.1442-2042.2012.02966.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
291 Kerckhoffs AP, ter Linde JJ, Akkermans LM, Samsom M. SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine. Am J Physiol Gastrointest Liver Physiol. 2012;302:G1053-G1060. [PMID: 22323131 DOI: 10.1152/ajpgi.00153.2011] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 6.0] [Reference Citation Analysis]
292 Schmulson M, Chey WD. Editorial: Abnormal Immune Regulation and Low-Grade Inflammation in IBS: Does One Size Fit All? American Journal of Gastroenterology 2012;107:273-5. [DOI: 10.1038/ajg.2011.427] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
293 Buhner S, Schemann M. Mast cell–nerve axis with a focus on the human gut. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2012;1822:85-92. [DOI: 10.1016/j.bbadis.2011.06.004] [Cited by in Crossref: 95] [Cited by in F6Publishing: 102] [Article Influence: 9.5] [Reference Citation Analysis]
294 Fernández-Carvajal A, Fernández-Ballester G, Devesa I, González-Ros JM, Ferrer-Montiel A. New strategies to develop novel pain therapies: addressing thermoreceptors from different points of view. Pharmaceuticals (Basel) 2011;5:16-48. [PMID: 24288041 DOI: 10.3390/ph5010016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
295 Chang L, Adeyemo M, Karagiannides I, Videlock EJ, Bowe C, Shih W, Presson AP, Yuan PQ, Cortina G, Gong H. Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol. 2012;107:262-272. [PMID: 22158028 DOI: 10.1038/ajg.2011.423] [Cited by in Crossref: 111] [Cited by in F6Publishing: 118] [Article Influence: 10.1] [Reference Citation Analysis]
296 Barbara G, Cremon C, Carini G, Bellacosa L, Zecchi L, De Giorgio R, Corinaldesi R, Stanghellini V. The immune system in irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17:349-359. [PMID: 22148103 DOI: 10.5056/jnm.2011.17.4.349] [Cited by in Crossref: 137] [Cited by in F6Publishing: 143] [Article Influence: 12.5] [Reference Citation Analysis]
297 Barbara G, Cremon C, De Giorgio R, Dothel G, Zecchi L, Bellacosa L, Carini G, Stanghellini V, Corinaldesi R. Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome. Curr Gastroenterol Rep. 2011;13:308-315. [PMID: 21537962 DOI: 10.1007/s11894-011-0195-7] [Cited by in Crossref: 83] [Cited by in F6Publishing: 73] [Article Influence: 7.5] [Reference Citation Analysis]
298 Walker MM, Warwick A, Ung C, Talley NJ. The role of eosinophils and mast cells in intestinal functional disease. Curr Gastroenterol Rep. 2011;13:323-330. [PMID: 21552990 DOI: 10.1007/s11894-011-0197-5] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
299 Yiangou Y, Anand U, Otto WR, Sinisi M, Fox M, Birch R, Foster KA, Mukerji G, Akbar A, Agarwal SK, Anand P. Increased levels of SV2A botulinum neurotoxin receptor in clinical sensory disorders and functional effects of botulinum toxins A and E in cultured human sensory neurons. J Pain Res 2011;4:347-55. [PMID: 22090803 DOI: 10.2147/JPR.S25189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 0.2] [Reference Citation Analysis]
300 Spiller R, Lam C. The shifting interface between IBS and IBD. Curr Opin Pharmacol. 2011;11:586-592. [PMID: 22000604 DOI: 10.1016/j.coph.2011.09.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
301 Bulmer DC, Grundy D. Achieving translation in models of visceral pain. Curr Opin Pharmacol. 2011;11:575-581. [PMID: 22000605 DOI: 10.1016/j.coph.2011.09.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
302 Schicho R, Storr M. Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases. Can J Gastroenterol 2011;25:377-83. [PMID: 21876860 DOI: 10.1155/2011/953975] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
303 Führer M, Vogelsang H, Hammer J. A placebo-controlled trial of an oral capsaicin load in patients with functional dyspepsia. Neurogastroenterol Motil. 2011;23:918-e397. [PMID: 21883698 DOI: 10.1111/j.1365-2982.2011.01766.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
304 Anand P, Bley K. Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth 2011;107:490-502. [PMID: 21852280 DOI: 10.1093/bja/aer260] [Cited by in Crossref: 406] [Cited by in F6Publishing: 437] [Article Influence: 36.9] [Reference Citation Analysis]
305 Holzer P. TRP channels in the digestive system. Curr Pharm Biotechnol. 2011;12:24-34. [PMID: 20932260 DOI: 10.2174/138920111793937862] [Cited by in Crossref: 72] [Cited by in F6Publishing: 76] [Article Influence: 6.5] [Reference Citation Analysis]
306 Harrington AM, Hughes PA, Martin CM, Yang J, Castro J, Isaacs NJ, Blackshaw AL, Brierley SM. A novel role for TRPM8 in visceral afferent function. Pain 2011;152:1459-68. [DOI: 10.1016/j.pain.2011.01.027] [Cited by in Crossref: 105] [Cited by in F6Publishing: 89] [Article Influence: 9.5] [Reference Citation Analysis]
307 Cao Y, Wilder-smith CH, Li XH, Wong RKM, Hammer J, Ho KY. Characterization of a reproducible gastric pain model using oral capsaicin titration in healthy volunteers: Gastric pain using oral capsaicin titration. Neurogastroenterology & Motility 2011;23:e261-70. [DOI: 10.1111/j.1365-2982.2011.01734.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
308 Jiang W, Kirkup AJ, Grundy D. Mast cells drive mesenteric afferent signalling during acute intestinal ischaemia. J Physiol. 2011;589:3867-3882. [PMID: 21669977 DOI: 10.1113/jphysiol.2011.209478] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
309 Hasler WL. Traditional thoughts on the pathophysiology of irritable bowel syndrome. Gastroenterol Clin North Am. 2011;40:21-43. [PMID: 21333899 DOI: 10.1016/j.gtc.2010.12.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
310 Devesa I, Planells-Cases R, Fernández-Ballester G, González-Ros JM, Ferrer-Montiel A, Fernández-Carvajal A. Role of the transient receptor potential vanilloid 1 in inflammation and sepsis. J Inflamm Res 2011;4:67-81. [PMID: 22096371 DOI: 10.2147/JIR.S12978] [Cited by in Crossref: 9] [Cited by in F6Publishing: 24] [Article Influence: 0.8] [Reference Citation Analysis]
311 Bortolotti M, Porta S. Effect of red pepper on symptoms of irritable bowel syndrome: preliminary study. Dig Dis Sci 2011;56:3288-95. [PMID: 21573941 DOI: 10.1007/s10620-011-1740-9] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 4.2] [Reference Citation Analysis]
312 van Diest SA, Stanisor OI, Boeckxstaens GE, de Jonge WJ, van den Wijngaard RM. Relevance of mast cell-nerve interactions in intestinal nociception. Biochim Biophys Acta 2012;1822:74-84. [PMID: 21496484 DOI: 10.1016/j.bbadis.2011.03.019] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 5.5] [Reference Citation Analysis]
313 Asfaw TS, Hypolite J, Northington GM, Arya LA, Wein AJ, Malykhina AP. Acute colonic inflammation triggers detrusor instability via activation of TRPV1 receptors in a rat model of pelvic organ cross-sensitization. Am J Physiol Regul Integr Comp Physiol 2011;300:R1392-400. [PMID: 21474425 DOI: 10.1152/ajpregu.00804.2010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
314 Boesmans W, Owsianik G, Tack J, Voets T, Vanden Berghe P. TRP channels in neurogastroenterology: opportunities for therapeutic intervention. Br J Pharmacol 2011;162:18-37. [PMID: 20804496 DOI: 10.1111/j.1476-5381.2010.01009.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 5.6] [Reference Citation Analysis]
315 Mcdougall JJ. Peripheral analgesia: Hitting pain where it hurts. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2011;1812:459-67. [DOI: 10.1016/j.bbadis.2010.12.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
316 Holzer P. Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system. Pharmacol Ther 2011;131:142-70. [PMID: 21420431 DOI: 10.1016/j.pharmthera.2011.03.006] [Cited by in Crossref: 154] [Cited by in F6Publishing: 165] [Article Influence: 14.0] [Reference Citation Analysis]
317 Cunin P, Caillon A, Corvaisier M, Garo E, Scotet M, Blanchard S, Delneste Y, Jeannin P. The Tachykinins Substance P and Hemokinin-1 Favor the Generation of Human Memory Th17 Cells by Inducing IL-1β, IL-23, and TNF-Like 1A Expression by Monocytes. J I 2011;186:4175-82. [DOI: 10.4049/jimmunol.1002535] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 6.5] [Reference Citation Analysis]
318 Elsenbruch S. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms. Brain Behav Immun. 2011;25:386-394. [PMID: 21094682 DOI: 10.1016/j.bbi.2010.11.010] [Cited by in Crossref: 198] [Cited by in F6Publishing: 223] [Article Influence: 16.5] [Reference Citation Analysis]
319 Lo MW, Matsumoto K, Iwai M, Tashima K, Kitajima M, Horie S, Takayama H. Inhibitory effect of Iboga-type indole alkaloids on capsaicin-induced contraction in isolated mouse rectum. J Nat Med 2011;65:157-65. [DOI: 10.1007/s11418-010-0478-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
320 Taylor TJ, Youssef NN, Shankar R, Kleiner DE, Henderson WA. The association of mast cells and serotonin in children with chronic abdominal pain of unknown etiology. BMC Res Notes. 2010;3:265. [PMID: 20964845 DOI: 10.1186/1756-0500-3-265] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
321 Matsumoto K, Hosoya T, Tashima K, Namiki T, Murayama T, Horie S. Distribution of transient receptor potential vanilloid 1 channel-expressing nerve fibers in mouse rectal and colonic enteric nervous system: relationship to peptidergic and nitrergic neurons. Neuroscience. 2011;172:518-534. [PMID: 20951772 DOI: 10.1016/j.neuroscience.2010.10.024] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
322 Qin HY, Luo JL, Qi SD, Xu HX, Sung JJ, Bian ZX. Visceral hypersensitivity induced by activation of transient receptor potential vanilloid type 1 is mediated through the serotonin pathway in rat colon. Eur J Pharmacol 2010;647:75-83. [PMID: 20826151 DOI: 10.1016/j.ejphar.2010.08.019] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
323 Brierley SM, Hughes PA, Harrington AM, Rychkov GY, Blackshaw LA. Identifying the Ion Channels Responsible for Signaling Gastro-Intestinal Based Pain. Pharmaceuticals (Basel) 2010;3:2768-98. [PMID: 27713376 DOI: 10.3390/ph3092768] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
324 Shieh KR, Yi CH, Liu TT, Tseng HL, Ho HC, Hsieh HT, Chen CL. Evidence for neurotrophic factors associating with TRPV1 gene expression in the inflamed human esophagus: TRPV1 and neurotrophic factors in GERD. Neurogastroenterology & Motility 2010;22:971-e252. [DOI: 10.1111/j.1365-2982.2010.01530.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
325 Gonlachanvit S. Are rice and spicy diet good for functional gastrointestinal disorders? J Neurogastroenterol Motil. 2010;16:131-138. [PMID: 20535343 DOI: 10.5056/jnm.2010.16.2.131] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 4.8] [Reference Citation Analysis]
326 van Boxel OS, ter Linde JJ, Siersema PD, Smout AJ. Role of chemical stimulation of the duodenum in dyspeptic symptom generation. Am J Gastroenterol 2010;105:803-11; quiz 802, 812. [PMID: 20234343 DOI: 10.1038/ajg.2010.100] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
327 Holzer P, Holzer-Petsche U. Pharmacology of inflammatory pain: local alteration in receptors and mediators. Dig Dis 2009;27 Suppl 1:24-30. [PMID: 20203494 DOI: 10.1159/000268118] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
328 Powell N, Walker MM, Talley NJ. Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol. 2010;7:146-156. [PMID: 20125092 DOI: 10.1038/nrgastro.2010.5] [Cited by in Crossref: 80] [Cited by in F6Publishing: 86] [Article Influence: 6.7] [Reference Citation Analysis]
329 Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. 2010;7:163-173. [PMID: 20101257 DOI: 10.1038/nrgastro.2010.4] [Cited by in Crossref: 394] [Cited by in F6Publishing: 436] [Article Influence: 32.8] [Reference Citation Analysis]
330 Talley NJ. Irritable Bowel Syndrome. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 2010. [DOI: 10.1016/b978-1-4160-6189-2.00118-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
331 Ryu K, Huh K. Irritable Bowel Syndrome in Inflammatory Bowel Disease. Intest Res 2010;8:95. [DOI: 10.5217/ir.2010.8.2.95] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
332 Fukudo S. 3) Irritable Bowel Syndrome (IBS). J Jpn Soc Intern Med 2010;99:2146-2157. [DOI: 10.2169/naika.99.2146] [Reference Citation Analysis]
333 Quinn MJ. Autonomic denervation and the origins of chronic Western diseases. Med Hypotheses 2010;74:937-44. [PMID: 20022182 DOI: 10.1016/j.mehy.2009.11.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
334 Zhang ZQ, Wang Q, Wang BJ. Relationship between TRPV1 gene polymorphism and irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2009; 17(34): 3514-3518 [DOI: 10.11569/wcjd.v17.i34.3514] [Reference Citation Analysis]
335 Shekhar C, Whorwell PJ. Emerging drugs for irritable bowel syndrome. Expert Opinion on Emerging Drugs 2009;14:673-85. [DOI: 10.1517/14728210903222279] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
336 Sengupta JN. Visceral pain: the neurophysiological mechanism. Handb Exp Pharmacol. 2009;31-74. [PMID: 19655104 DOI: 10.1007/978-3-540-79090-7_2] [Cited by in Crossref: 122] [Cited by in F6Publishing: 93] [Article Influence: 9.4] [Reference Citation Analysis]
337 van den wijngaard RM, klooker TK, welting O, stanisor OI, wouters MM, van der coelen D, bulmer DC, peeters PJ, aerssens J, de hoogt R, lee K, de jonge WJ, boeckxstaens GE. Essential role for TRPV1 in stress-induced (mast cell-dependent) colonic hypersensitivity in maternally separated rats. Neurogastroenterology & Motility 2009;21:1107-e94. [DOI: 10.1111/j.1365-2982.2009.01339.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 93] [Article Influence: 6.8] [Reference Citation Analysis]
338 Hamza M, Dionne RA. 2020 foresight: Envisioning therapeutic innovations for pain. Drug Discovery Today: Therapeutic Strategies 2009;6:113-119. [DOI: 10.1016/j.ddstr.2010.10.002] [Reference Citation Analysis]
339 Spiller R, Garsed K. Infection, inflammation, and the irritable bowel syndrome. Dig Liver Dis. 2009;41:844-849. [PMID: 19716778 DOI: 10.1016/j.dld.2009.07.007] [Cited by in Crossref: 87] [Cited by in F6Publishing: 100] [Article Influence: 6.7] [Reference Citation Analysis]
340 Traver E, Torres R, de Mora F, Vergara P. Mucosal mast cells mediate motor response induced by chronic oral exposure to ovalbumin in the rat gastrointestinal tract. Neurogastroenterol Motil 2010;22:e34-43. [PMID: 19682267 DOI: 10.1111/j.1365-2982.2009.01377.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
341 Vergnolle N. Visceral afferents: what role in post-inflammatory pain? Auton Neurosci 2010;153:79-83. [PMID: 19666242 DOI: 10.1016/j.autneu.2009.07.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
342 Knowles CH, De Giorgio R, Kapur RP, Bruder E, Farrugia G, Geboes K, Gershon MD, Hutson J, Lindberg G, Martin JE, Meier-Ruge WA, Milla PJ, Smith VV, Vandervinden JM, Veress B, Wedel T. Gastrointestinal neuromuscular pathology: guidelines for histological techniques and reporting on behalf of the Gastro 2009 International Working Group. Acta Neuropathol 2009;118:271-301. [PMID: 19360428 DOI: 10.1007/s00401-009-0527-y] [Cited by in Crossref: 156] [Cited by in F6Publishing: 125] [Article Influence: 12.0] [Reference Citation Analysis]
343 van den wijngaard RM, welting O, bulmer DC, wouters MM, lee K, de jonge WJ, boeckxstaens GE. Possible role for TRPV1 in neomycin-induced inhibition of visceral hypersensitivity in rat. Neurogastroenterology & Motility 2009;21:863-e60. [DOI: 10.1111/j.1365-2982.2009.01287.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
344 Farmer AD, Aziz Q. Visceral pain hypersensitivity in functional gastrointestinal disorders. Br Med Bull. 2009;91:123-136. [PMID: 19620136 DOI: 10.1093/bmb/ldp026] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 3.5] [Reference Citation Analysis]
345 Saunders CI, Fassett RG, Geraghty DP. Up-regulation of TRPV1 in mononuclear cells of end-stage kidney disease patients increases susceptibility to N-arachidonoyl-dopamine (NADA)-induced cell death. Biochim Biophys Acta 2009;1792:1019-26. [PMID: 19619644 DOI: 10.1016/j.bbadis.2009.07.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
346 Róka R, Gecse K, Wittmann T. Novel strategies and future landmarks in the treatment of irritable bowel syndrome. Therapy 2009;6:603-613. [DOI: 10.2217/thy.09.22] [Reference Citation Analysis]
347 Shinoda M, Feng B, Gebhart GF. Peripheral and central P2X receptor contributions to colon mechanosensitivity and hypersensitivity in the mouse. Gastroenterology. 2009;137:2096-2104. [PMID: 19549524 DOI: 10.1053/j.gastro.2009.06.048] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 3.8] [Reference Citation Analysis]
348 Eid S, Cortright D. Transient Receptor Potential Channels on Sensory Nerves. In: Canning BJ, Spina D, editors. Sensory Nerves. Berlin: Springer Berlin Heidelberg; 2009. pp. 261-81. [DOI: 10.1007/978-3-540-79090-7_8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
349 Matsumoto K, Kurosawa E, Terui H, Hosoya T, Tashima K, Murayama T, Priestley JV, Horie S. Localization of TRPV1 and contractile effect of capsaicin in mouse large intestine: high abundance and sensitivity in rectum and distal colon. Am J Physiol Gastrointest Liver Physiol 2009;297:G348-60. [PMID: 19497956 DOI: 10.1152/ajpgi.90578.2008] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 4.2] [Reference Citation Analysis]
350 Akbar A, Walters JR, Ghosh S. Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents. Aliment Pharmacol Ther. 2009;30:423-435. [PMID: 19493256 DOI: 10.1111/j.1365-2036.2009.04056.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
351 Vanhoutvin SA, Troost FJ, Kilkens TO, Lindsey PJ, Hamer HM, Jonkers DM, Venema K, Brummer RJ. The effects of butyrate enemas on visceral perception in healthy volunteers. Neurogastroenterol Motil. 2009;21:952-e76. [PMID: 19460106 DOI: 10.1111/j.1365-2982.2009.01324.x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 109] [Article Influence: 7.7] [Reference Citation Analysis]
352 De Winter BY, Bredenoord AJ, Van Nassauw L, De Man JG, De Schepper HU, Timmermans JP, Pelckmans PA. Involvement of afferent neurons in the pathogenesis of endotoxin-induced ileus in mice: role of CGRP and TRPV1 receptors. Eur J Pharmacol 2009;615:177-84. [PMID: 19445917 DOI: 10.1016/j.ejphar.2009.04.055] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
353 Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology. 2009;136:1979-1988. [PMID: 19457422 DOI: 10.1053/j.gastro.2009.02.074] [Cited by in Crossref: 479] [Cited by in F6Publishing: 524] [Article Influence: 36.8] [Reference Citation Analysis]
354 Phillis BD, Martin CM, Kang D, Larsson H, Lindström EA, Martinez V, Blackshaw LA. Role of TRPV1 in high-threshold rat colonic splanchnic afferents is revealed by inflammation. Neurosci Lett 2009;459:57-61. [PMID: 19406204 DOI: 10.1016/j.neulet.2009.04.051] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
355 Ravnefjord A, Brusberg M, Kang D, Bauer U, Larsson H, Lindström E, Martinez V. Involvement of the transient receptor potential vanilloid 1 (TRPV1) in the development of acute visceral hyperalgesia during colorectal distension in rats. Eur J Pharmacol. 2009;611:85-91. [PMID: 19344705 DOI: 10.1016/j.ejphar.2009.03.058] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
356 Mawe GM, Strong DS, Sharkey KA. Plasticity of enteric nerve functions in the inflamed and postinflamed gut. Neurogastroenterol Motil. 2009;21:481-491. [PMID: 19368664 DOI: 10.1111/j.1365-2982.2009.01291.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 5.5] [Reference Citation Analysis]
357 Cremon C, Pallotti F, Bacchilega M, Stanghellini V, Corinaldesi R, Barbara G. Antiflagellin antibodies suggest infective participation in irritable bowel syndrome pathogenesis. Expert Rev Gastroenterol Hepatol. 2008;2:735-740. [PMID: 19090734 DOI: 10.1586/17474124.2.6.735] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
358 Karagiannides I, Pothoulakis C. Substance P, obesity, and gut inflammation. Curr Opin Endocrinol Diabetes Obes 2009;16:47-52. [PMID: 19104238 DOI: 10.1097/MED.0b013e328321306c] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
359 Ropert A, Bouguen G. Troubles de la motricité intestinale et hypersensibilité viscérale dans le syndrome de l’intestin irritable. Gastroentérologie Clinique et Biologique 2009;33:S35-9. [DOI: 10.1016/s0399-8320(09)71523-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
360 Hong S, Fan J, Kemmerer ES, Evans S, Li Y, Wiley JW. Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat. Gut 2009;58:202-10. [PMID: 18936104 DOI: 10.1136/gut.2008.157594] [Cited by in Crossref: 94] [Cited by in F6Publishing: 101] [Article Influence: 7.2] [Reference Citation Analysis]
361 Ohashi-doi K, Kurebayashi Y. An experimental model of visceral pain: its application to explore molecular targets for IBS therapy. Folia Pharmacol Jpn 2009;133:194-198. [DOI: 10.1254/fpj.133.194] [Reference Citation Analysis]
362 Führer M, Hammer J. Effect of repeated, long term capsaicin ingestion on intestinal chemo- and mechanosensation in healthy volunteers. Neurogastroenterol Motil. 2009;21:521-557, e7. [PMID: 19126186 DOI: 10.1111/j.1365-2982.2008.01227.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
363 Storr MA, Yüce B, Andrews CN, Sharkey KA. The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome. Neurogastroenterol Motil. 2008;20:857-868. [PMID: 18710476 DOI: 10.1111/j.1365-2982.2008.01175.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 67] [Article Influence: 4.3] [Reference Citation Analysis]
364 Hong S, Fan J, Kemmerer ES, Evans S, Li Y, Wiley JW. Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat. Gut. 2009;58:202-210. [PMID: 18936104 DOI: 10.1016/s0016-5085(08)62579-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
365 Bradesi S, Herman J, Mayer EA. Visceral analgesics: drugs with a great potential in functional disorders? Curr Opin Pharmacol. 2008;8:697-703. [PMID: 18786654 DOI: 10.1016/j.coph.2008.08.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
366 Holzer P. The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor. Br J Pharmacol 2008;155:1145-62. [PMID: 18806809 DOI: 10.1038/bjp.2008.351] [Cited by in Crossref: 130] [Cited by in F6Publishing: 140] [Article Influence: 9.3] [Reference Citation Analysis]
367 Patients with IBS have increased numbers of capsaicin-receptor nerve fibers. Nat Rev Gastroenterol Hepatol 2008;5:476-476. [DOI: 10.1038/ncpgasthep1211] [Reference Citation Analysis]
368 Holzer P. TRPV1: a new target for treatment of visceral pain in IBS? Gut 2008;57:882-4. [PMID: 18559382 DOI: 10.1136/gut.2008.149724] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
369 Spiller R. Review article: probiotics and prebiotics in irritable bowel syndrome. Aliment Pharmacol Ther. 2008;28:385-396. [PMID: 18532993 DOI: 10.1111/j.1365-2036.2008.03750.x] [Cited by in Crossref: 118] [Cited by in F6Publishing: 129] [Article Influence: 8.4] [Reference Citation Analysis]